Fund rankings
Most skilled, after luck
Return over stocks of the same sector and size, per year, over up to 8 quarters, pulled toward zero by how noisy each record is| # | Fund | Skill, per year | Raw, per year | Quarters ahead | Confidence (t) | Biggest contributor, 12 months |
|---|---|---|---|---|---|---|
| 1 | Kohlberg Kravis Roberts & Co. L.P.NEW YORK, NY · 17 positions · $5.5B | +19.0% | +36.6% | 8 of 8 | 5.1 | BTSGBrightspring Health Services+59 pts of +64% · Held by Q2 2024 at $11.36, $69.74 at Q2 2026 |
| 2 | Empirical Capital Management, LLCHENDERSONVILLE, TN · 17 positions · $366M | +12.8% | +23.3% | 7 of 8 | 3.4 | ROKURoku Inc+11 pts of +29% · Held by Q2 2024 at $59.93, $138 at Q2 2026 |
| 3 | Canerector IncTORONTO, A6 · 9 positions · $219M | +12.3% | +18.0% | 5 of 6 | 3.5 | TDToronto-Dominion Bank+7 pts of +40% · First reported Q4 2024 at $53.24, $121 at Q2 2026 |
| 4 | AltraVue Capital, LLCBELLEVUE, WA · 26 positions · $1.4B | +11.3% | +14.3% | 6 of 8 | 3.7 | AGXArgan Inc+8 pts of +37% · Held by Q2 2024 at $73.16, $799 at Q2 2026 |
| 5 | Talos Eurisko Asset Management LPNEW YORK, NY · 24 positions · $681M | +11.0% | +25.5% | 5 of 6 | 2.9 | WDCWestern Digital Corp+39 pts of +195% · First reported Q2 2025 at $63.99, $639 at Q2 2026 |
| 6 | Blue Grotto Capital, LLCATLANTA, GA · 29 positions · $1.2B | +10.9% | +19.2% | 7 of 8 | 2.9 | MKSIMks Inc+16 pts of +46% · Held by Q2 2024 at $131, $445 at Q2 2026 |
| 7 | WT Asset Management LtdHONG KONG, K3 · 24 positions · $5.0B | +10.4% | +24.1% | 7 of 8 | 2.8 | LITELumentum Holdings Inc+25 pts of +136% · First reported Q2 2025 at $95.06, $858 at Q2 2026 |
| 8 | Kerrisdale Advisers, LLCMiami, FL · 114 positions · $399M | +10.3% | +20.7% | 6 of 8 | 2.7 | STXSeagate Technology Holdings+15 pts of +68% · Held by Q2 2024 at $103, $965 at Q2 2026 |
| 9 | Covalis Capital LLPLONDON, X0 · 100 positions · $1.8B | +10.2% | +15.4% | 7 of 8 | 2.9 | CATCaterpillar Inc+3 pts of +38% · First reported Q2 2025 at $388, $1,065 at Q2 2026 |
| 10 | Allen Operations LLCNEW YORK, NY · 33 positions · $722M | +10.1% | +18.6% | 6 of 8 | 2.7 | AYIAcuity Inc+4 pts of +5% · Held by Q2 2024 at $241, $377 at Q2 2026 |
| 11 | Sachem Head Capital Management LPNEW YORK, NY · 19 positions · $4.8B | +10.1% | +15.5% | 7 of 8 | 2.8 | COHRCoherent Corp+13 pts of +36% · Held by Q2 2024 at $72.46, $394 at Q2 2026 |
| 12 | BlackBarn Capital Partners LPNEW YORK, NY · 17 positions · $402M | +9.9% | +19.9% | 6 of 8 | 2.6 | ROIVRoivant Sciences Ltd+34 pts of +85% · Held by Q2 2024 at $10.57, $35.39 at Q2 2026 |
| 13 | Bornite Capital Management LPNEW YORK, NY · 20 positions · $795M | +9.6% | +17.2% | 7 of 8 | 2.6 | CRSCarpenter Technology+10 pts of +49% · First reported Q2 2025 at $276, $617 at Q2 2026 |
| 14 | Baker Bros. Advisors LPNEW YORK, NY · 83 positions · $19.9B | +9.5% | +24.3% | 7 of 8 | 2.6 | INCYIncyte Corp+13 pts of +70% · Held by Q2 2024 at $60.62, $113 at Q2 2026 |
| 15 | Donald Smith & Co., Inc.NEW YORK, NY · 66 positions · $5.6B | +9.4% | +14.3% | 6 of 8 | 2.6 | IAGIamgold Corp+6 pts of +39% · Held by Q2 2024 at $3.75, $15.84 at Q2 2026 |
| 16 | CMT Capital Markets Trading GmbHCHICAGO, IL · 103 positions · $191M | +9.2% | +14.9% | 6 of 8 | 2.5 | MUMicron Technology Inc+11 pts of +40% · Held by Q2 2024 at $132, $1,154 at Q2 2026 |
| 17 | Madison Avenue Partners, LPNEW YORK, NY · 25 positions · $2.3B | +9.1% | +35.5% | 7 of 8 | 2.8 | SNDKSandisk Corp+76 pts of +129% · First reported Q2 2025 at $45.35, $2,274 at Q2 2026 |
| 18 | QVT Financial LPNew York, NY · 70 positions · $1.5B | +9.0% | +33.4% | 7 of 8 | 2.7 | ROIVRoivant Sciences Ltd+107 pts of +142% · Held by Q2 2024 at $10.57, $35.39 at Q2 2026 |
| 19 | Duquesne Family Office LLCNew York, NY · 86 positions · $4.4B | +9.0% | +16.8% | 6 of 8 | 2.4 | NTRANatera Inc+13 pts of +49% · Held by Q2 2024 at $108, $271 at Q2 2026 |
| 20 | Marathon Partners Equity Management, LLCNew York, NY · 14 positions · $102M | +8.9% | +14.5% | 6 of 6 | 2.4 | XMTRXometry Inc-A+11 pts of +20% · First reported Q4 2024 at $42.66, $96.52 at Q2 2026 |
| 21 | Four Tree Island Advisory LLCPORTSMOUTH, NH · 24 positions · $303M | +8.7% | +22.0% | 6 of 6 | 2.4 | LRCXLam Research Corp+53 pts of +98% · First reported Q4 2024 at $72.23, $433 at Q2 2026 |
| 22 | Apis Capital Advisors, LLCNew York, NY · 60 positions · $1.0B | +8.5% | +28.4% | 6 of 8 | 2.5 | WDCWestern Digital Corp+19 pts of +140% · First reported Q3 2025 at $120, $639 at Q2 2026 |
| 23 | Merewether Investment Management, LPDALLAS, TX · 81 positions · $5.3B | +8.5% | +11.5% | 7 of 8 | 2.6 | MTZMastec Inc+3 pts of +35% · First reported Q4 2024 at $136, $416 at Q2 2026 |
| 24 | Whitefort Capital Management, LPNEW YORK, NY · 18 positions · $392M | +8.5% | +23.2% | 7 of 8 | 2.3 | ROIVRoivant Sciences Ltd+28 pts of +96% · Held by Q2 2024 at $10.57, $35.39 at Q2 2026 |
| 25 | RV Capital AGSchindellegi, V8 · 13 positions · $383M | +8.4% | +11.2% | 6 of 7 | 2.6 | — |
| 26 | FengHe Fund Management Pte. Ltd.Singapore, U0 · 18 positions · $1.1B | +8.4% | +40.9% | 6 of 8 | 2.8 | MKSIMks Inc+28 pts of +196% · First reported Q1 2026 at $230, $445 at Q2 2026 |
| 27 | Monaco Asset Management SAMMonaco, O9 · 36 positions · $269M | +8.3% | +17.3% | 6 of 8 | 2.2 | PTENPatterson-Uti Energy Inc+10 pts of +71% · First reported Q3 2024 at $7.65, $9.18 at Q2 2026 |
| 28 | Castle Hook Partners LPNEW YORK, NY · 66 positions · $9.3B | +8.1% | +25.0% | 7 of 8 | 2.3 | WDCWestern Digital Corp+12 pts of +45% · First reported Q2 2025 at $63.99, $639 at Q2 2026 |
| 29 | Panoramic Capital, LLCLARKSPUR, CA · 43 positions · $232M | +8.0% | +30.9% | 5 of 6 | 2.4 | STXSeagate Technology Holdings+36 pts of +103% · First reported Q4 2024 at $86.31, $965 at Q2 2026 |
| 30 | First Sabrepoint Capital Management LPDALLAS, TX · 20 positions · $234M | +8.0% | +11.9% | 6 of 8 | 2.3 | STRLSterling Infrastructure Inc+7 pts of +35% · Held by Q2 2024 at $118, $839 at Q2 2026 |
| 31 | Bosman Wealth Management, LLCRedlands, CA · 56 positions · $161M | +7.8% | +15.7% | 5 of 6 | 2.1 | MUMicron Technology Inc+12 pts of +32% · First reported Q1 2026 at $338, $1,154 at Q2 2026 |
| 32 | Keystone Investors Pte LtdSINGAPORE, U0 · 84 positions · $1.9B | +7.8% | +10.6% | 5 of 7 | 2.3 | — |
| 33 | Ophir Asset Management Pty LtdSYDNEY, C3 · 36 positions · $1.2B | +7.8% | +24.7% | 7 of 8 | 2.2 | SIMOSilicon Motion Technol-Adr+13 pts of +67% · First reported Q2 2025 at $75.17, $333 at Q2 2026 |
| 34 | CPV Partners, LLCSTAMFORD, CT · 5 positions · $274M | +7.7% | +39.9% | 6 of 8 | 2.6 | LAURLaureate Education Inc+41 pts of +29% · Held by Q2 2024 at $14.94, $36.32 at Q2 2026 |
| 35 | Gate City Capital Management, LLCCHICAGO, IL · 17 positions · $386M | +7.7% | +17.0% | 6 of 8 | 2.0 | BTUPeabody Energy Corp+7 pts of +39% · First reported Q3 2024 at $26.54, $23.12 at Q2 2026 |
| 36 | Thames Capital Management LLCRoseland, NJ · 56 positions · $1.2B | +7.6% | +13.5% | 6 of 8 | 2.0 | MUMicron Technology Inc+10 pts of +64% · First reported Q2 2025 at $123, $1,154 at Q2 2026 |
| 37 | Brightline Capital Management, LLCMiami, FL · 11 positions · $462M | +7.5% | +50.9% | 6 of 8 | 2.8 | VSATViasat Inc+86 pts of +156% · First reported Q2 2025 at $14.60, $89.81 at Q2 2026 |
| 38 | No Street GP LPSan Francisco, CA · 32 positions · $1.7B | +7.5% | +18.3% | 5 of 8 | 2.0 | APPApplovin Corp-Class A+7 pts of +22% · Held by Q2 2024 at $83.22, $515 at Q2 2026 |
| 39 | Manatuck Hill Partners, LLCWESTPORT, CT · 129 positions · $302M | +7.4% | +10.3% | 6 of 8 | 2.2 | REALRealreal Inc/The+4 pts of +40% · Held by Q2 2024 at $3.19, $11.79 at Q2 2026 |
| 40 | Gator Capital Management, LLCTAMPA, FL · 67 positions · $465M | +7.3% | +13.7% | 5 of 8 | 2.0 | Anywhere Real Estate Inc+8 pts of +30% · Held by Q2 2024 at $3.31 |
| 41 | Andar Capital Management HK LtdHONG KONG, K3 · 13 positions · $223M | +7.3% | +34.5% | 6 of 8 | 2.4 | SMTCSemtech Corp+31 pts of +198% · First reported Q2 2025 at $45.14, $162 at Q2 2026 |
| 42 | Recurrent Investment Advisors LLCHOUSTON, TX · 71 positions · $1.6B | +7.3% | +8.6% | 7 of 8 | 2.7 | CVECenovus Energy Inc+6 pts of +30% · Held by Q2 2024 at $19.66, $24.81 at Q2 2026 |
| 43 | GMT Capital CorpATLANTA, GA · 68 positions · $1.9B | +7.3% | +11.7% | 6 of 8 | 2.0 | HBMHudbay Minerals Inc+18 pts of +47% · Held by Q2 2024 at $9.05, $23.61 at Q2 2026 |
| 44 | Summit Partners Public Asset Management, LLCBoston, MA · 79 positions · $3.8B | +7.3% | +22.8% | 7 of 8 | 2.1 | SNDKSandisk Corp+15 pts of +80% · First reported Q2 2025 at $45.35, $2,274 at Q2 2026 |
| 45 | Catalio Capital Management, LPNEW YORK, NY · 39 positions · $532M | +7.2% | +17.7% | 4 of 6 | 2.0 | DNTHDianthus Therapeutics Inc+13 pts of +77% · First reported Q4 2024 at $21.80, $97.48 at Q2 2026 |
| 46 | Two Seas Capital LPRYE, NY · 37 positions · $2.6B | +7.2% | +35.3% | 7 of 8 | 2.4 | ROIVRoivant Sciences Ltd+22 pts of +123% · Held by Q2 2024 at $10.57, $35.39 at Q2 2026 |
| 47 | P Schoenfeld Asset Management LPNEW YORK, NY · 25 positions · $168M | +7.2% | +9.8% | 6 of 8 | 2.2 | IAGIamgold Corp+9 pts of +29% · Held by Q2 2024 at $3.75, $15.84 at Q2 2026 |
| 48 | Whale Rock Capital Management LLCBoston, MA · 35 positions · $12.5B | +7.2% | +24.2% | 6 of 8 | 2.1 | CLSCelestica Inc+10 pts of +83% · Held by Q2 2024 at $57.33, $365 at Q2 2026 |
| 49 | Sessa Capital IM, L.P.NEW YORK, NY · 26 positions · $5.8B | +7.1% | +22.8% | 6 of 8 | 2.0 | WBDWarner Bros Discovery Inc+24 pts of +71% · Held by Q2 2024 at $7.44, $26.66 at Q2 2026 |
| 50 | Kopernik Global Investors, LLCTAMPA, FL · 26 positions · $1.6B | +7.1% | +24.6% | 5 of 8 | 2.1 | BBarrick Mining Corp+10 pts of +55% · First reported Q2 2025 at $20.82, $36.73 at Q2 2026 |
| 51 | Incline Global Management LLCNew York, NY · 20 positions · $357M | +7.1% | +12.5% | 6 of 8 | 1.9 | CRDOCredo Technology Group Holdi+12 pts of +31% · First reported Q1 2026 at $93.87, $272 at Q2 2026 |
| 52 | Pennant Investors, LPSummit, NJ · 16 positions · $335M | +7.0% | +24.6% | 6 of 8 | 2.1 | ECHOEchostar Corp-A+31 pts of +67% · Held by Q2 2024 at $17.81, $102 at Q2 2026 |
| 53 | Generali Powszechne Towarzystwo EmerytalneWARSAW, R9 · 25 positions · $631M | +7.0% | +16.2% | 6 of 8 | 1.9 | MUMicron Technology Inc+16 pts of +27% · First reported Q4 2024 at $84.16, $1,154 at Q2 2026 |
| 54 | Kensico Capital Management CorpGREENWICH, CT · 25 positions · $5.8B | +7.0% | +22.2% | 7 of 8 | 2.0 | APPApplovin Corp-Class A+9 pts of +11% · Held by Q2 2024 at $83.22, $515 at Q2 2026 |
| 55 | Intrinsic Edge Capital Management LLCCHICAGO, IL · 102 positions · $811M | +7.0% | +14.6% | 5 of 8 | 1.9 | GLWCorning Inc+7 pts of +46% · First reported Q4 2024 at $47.52, $255 at Q2 2026 |
| 56 | Jericho Capital Asset Management L.P.LOS ANGELES, CA · 29 positions · $12.1B | +6.9% | +29.6% | 6 of 8 | 2.2 | CIENCiena Corp+10 pts of +45% · First reported Q2 2025 at $81.33, $491 at Q2 2026 |
| 57 | Sharpepoint LLCPHOENIX, AZ · 89 positions · $200M | +6.9% | +10.5% | 5 of 6 | 1.9 | WDCWestern Digital Corp+6 pts of +34% · First reported Q4 2025 at $172, $639 at Q2 2026 |
| 58 | Hoertkorn Richard CharlesKENTFIELD, CA · 71 positions · $149M | +6.9% | +12.9% | 6 of 8 | 1.8 | Marvell Technology Group Ltd+15 pts of +44% · Held by Q2 2024 at $69.90, $298 at Q2 2026 |
| 59 | Oppenheimer & Close, LLCNEW YORK, NY · 57 positions · $159M | +6.9% | +9.9% | 6 of 8 | 2.0 | GLWCorning Inc+9 pts of +45% · Held by Q2 2024 at $38.85, $255 at Q2 2026 |
| 60 | Colrain Capital LLCBoston, MA · 25 positions · $295M | +6.8% | +13.4% | 5 of 6 | 1.8 | VICRVicor Corp+40 pts of +52% · First reported Q4 2024 at $48.32, $380 at Q2 2026 |
| 61 | Land & Buildings Investment Management, LLCSTAMFORD, CT · 19 positions · $583M | +6.8% | +8.7% | 7 of 8 | 2.2 | AHRAmerican Healthcare REIT Inc+3 pts of +23% · Held by Q2 2024 at $14.61, $52.15 at Q2 2026 |
| 62 | Plustick Management LLCCHARLOTTESVILLE, VA · 23 positions · $236M | +6.7% | +53.0% | 7 of 8 | 2.7 | APLDApplied Digital Corp+25 pts of +96% · Held by Q2 2024 at $5.95, $37.30 at Q2 2026 |
| 63 | Opaleye Management Inc.BOSTON, MA · 58 positions · $1.1B | +6.7% | +33.9% | 5 of 8 | 2.2 | LQDALiquidia Corp+35 pts of +127% · Held by Q2 2024 at $12.00, $79.73 at Q2 2026 |
| 64 | Nextech Invest Ltd.Zurich, V8 · 15 positions · $2.1B | +6.6% | +107.3% | 5 of 5 | 3.7 | RVMDRevolution Medicines Inc+217 pts of +310% · First reported Q1 2025 at $35.36, $187 at Q2 2026 |
| 65 | Analog Century Management LPNEW YORK, NY · 25 positions · $2.7B | +6.6% | +18.9% | 6 of 8 | 1.8 | LITELumentum Holdings Inc+23 pts of +182% · First reported Q1 2025 at $62.34, $858 at Q2 2026 |
| 66 | Credit Capital Investments LLCLIVINGSTON, NJ · 42 positions · $175M | +6.6% | +26.3% | 6 of 8 | 2.0 | MUMicron Technology Inc+86 pts of +143% · Held by Q2 2024 at $132, $1,154 at Q2 2026 |
| 67 | Octahedron Capital Management L.P.BURLINGAME, CA · 15 positions · $195M | +6.6% | +16.3% | 6 of 8 | 1.8 | INTCIntel Corp+15 pts of +51% · First reported Q4 2024 at $20.05, $140 at Q2 2026 |
| 68 | Lonestar Capital Management LLCSan Francisco, CA · 26 positions · $155M | +6.5% | +14.3% | 7 of 8 | 1.7 | GTXGarrett Motion Inc+16 pts of +38% · Held by Q2 2024 at $8.59, $36.23 at Q2 2026 |
| 69 | Rubric Capital Management LPNEW YORK, NY · 86 positions · $10.9B | +6.5% | +13.0% | 6 of 8 | 1.7 | FTAIFtai Aviation Ltd+8 pts of +47% · First reported Q1 2025 at $111, $271 at Q2 2026 |
| 70 | Zweig-DiMenna Associates LLCNEW YORK, NY · 70 positions · $1.1B | +6.5% | +12.9% | 6 of 8 | 1.7 | LITELumentum Holdings Inc+8 pts of +74% · First reported Q4 2024 at $83.95, $858 at Q2 2026 |
| 71 | Maple Rock Capital Partners Inc.Toronto, A6 · 51 positions · $5.1B | +6.5% | +30.0% | 6 of 8 | 2.1 | WDCWestern Digital Corp+61 pts of +140% · Held by Q2 2024 at $75.77, $639 at Q2 2026 |
| 72 | 1492 Capital Management LLCMILWAUKEE, WI · 131 positions · $338M | +6.5% | +10.8% | 6 of 8 | 1.8 | AAOIApplied Optoelectronics Inc+8 pts of +40% · First reported Q4 2025 at $34.86, $148 at Q2 2026 |
| 73 | Westerly Capital Management, LLCSAN FRANCISCO, CA · 46 positions · $542M | +6.5% | +13.4% | 6 of 8 | 1.7 | MRVLMarvell Technology Inc+17 pts of +73% · Held by Q2 2024 at $69.90, $298 at Q2 2026 |
| 74 | Pinnbrook Capital Management LPNEW YORK, NY · 88 positions · $601M | +6.5% | +9.7% | 6 of 8 | 1.8 | WDCWestern Digital Corp+6 pts of +44% · Held by Q2 2024 at $75.77, $639 at Q2 2026 |
| 75 | Mhr Fund Management LLCNEW YORK, NY · 11 positions · $1.9B | +6.4% | +42.1% | 6 of 7 | 2.4 | TSATTelesat Corp+51 pts of +103% · Held by Q2 2024 at $9.10, $50.62 at Q2 2026 |
| 76 | Evergreen Quality Fund GP, Ltd.GRAND CAYMAN, E9 · 43 positions · $6.2B | +6.4% | +34.2% | 6 of 8 | 2.2 | INTCIntel Corp+34 pts of +102% · First reported Q4 2025 at $36.90, $140 at Q2 2026 |
| 77 | Candelo Capital Management LPNEW YORK, NY · 27 positions · $136M | +6.4% | +16.7% | 6 of 8 | 1.7 | AMATApplied Materials Inc+8 pts of +68% · First reported Q4 2025 at $257, $723 at Q2 2026 |
| 78 | Minneapolis Portfolio Management Group, LLCWayzata, MN · 34 positions · $1.1B | +6.4% | +8.3% | 6 of 8 | 2.0 | GLWCorning Inc+16 pts of +56% · Held by Q2 2024 at $38.85, $255 at Q2 2026 |
| 79 | Frazier Life Sciences Management, L.P.PALO ALTO, CA · 41 positions · $4.6B | +6.3% | +22.5% | 5 of 8 | 1.9 | MIRMMirum Pharmaceuticals Inc+21 pts of +102% · Held by Q2 2024 at $34.19, $117 at Q2 2026 |
| 80 | SG Capital Management LLCCHICAGO, IL · 76 positions · $1.1B | +6.3% | +12.3% | 5 of 8 | 1.7 | LITELumentum Holdings Inc+7 pts of +49% · First reported Q3 2024 at $63.38, $858 at Q2 2026 |
| 81 | HighVista Strategies LLCBOSTON, MA · 147 positions · $439M | +6.3% | +15.3% | 5 of 7 | 1.7 | COGTCogent Biosciences Inc+4 pts of +87% · Held by Q2 2024 at $8.43, $38.70 at Q2 2026 |
| 82 | Western Financial Corp/CASAN DIEGO, CA · 132 positions · $341M | +6.1% | +13.3% | 6 of 8 | 1.6 | ARWRArrowhead Pharmaceuticals in+27 pts of +57% · Held by Q2 2024 at $25.99, $81.51 at Q2 2026 |
| 83 | Kazazian Asset Management, LLCFORT LAUDERDALE, FL · 51 positions · $111M | +6.1% | +11.7% | 4 of 6 | 1.6 | GOOGAlphabet Inc-Cl C+12 pts of +24% · First reported Q4 2024 at $190, $353 at Q2 2026 |
| 84 | Shellback Capital, LPBoston, MA · 89 positions · $1.1B | +6.1% | +14.4% | 6 of 8 | 1.6 | AMDAdvanced Micro Devices+6 pts of +34% · First reported Q1 2026 at $203, $581 at Q2 2026 |
| 85 | Bayberry Capital Partners LPNEW YORK, NY · 27 positions · $290M | +6.1% | +13.6% | 6 of 8 | 1.6 | LIONLionsgate Studios Corp+10 pts of +29% · First reported Q2 2025 at $5.81, $15.31 at Q2 2026 |
| 86 | Tribune Investment Group LPNEW YORK, NY · 32 positions · $148M | +6.0% | +8.6% | 5 of 6 | 1.7 | CATCaterpillar Inc+5 pts of +36% · First reported Q3 2025 at $477, $1,065 at Q2 2026 |
| 87 | Oasis Management Co Ltd.GRAND CAYMAN, E9 · 101 positions · $860M | +6.0% | +24.1% | 6 of 8 | 1.8 | HUTHut 8 Corp+27 pts of +39% · First reported Q2 2025 at $18.60, $115 at Q2 2026 |
| 88 | Newlands Management Operations LLCDALLAS, TX · 16 positions · $16.6B | +5.9% | +14.1% | 5 of 8 | 1.6 | GOOGLAlphabet Inc-Cl A+6 pts of −6% · Held by Q2 2024 at $182, $357 at Q2 2026 |
| 89 | Kamunting Street Capital Management, L.P.MIAMI BEACH, FL · 25 positions · $179M | +5.9% | +15.2% | 7 of 8 | 1.6 | MUMicron Technology Inc+19 pts of +37% · First reported Q3 2024 at $104, $1,154 at Q2 2026 |
| 90 | Yaupon Capital Management LPNEW YORK, NY · 109 positions · $3.0B | +5.9% | +6.7% | 6 of 8 | 2.4 | HUTHut 8 Corp+4 pts of +33% · First reported Q1 2025 at $11.62, $115 at Q2 2026 |
| 91 | CloudAlpha Capital Management Limited/Hong KongHONG KONG, K3 · 24 positions · $1.0B | +5.9% | +37.0% | 6 of 8 | 2.1 | LITELumentum Holdings Inc+19 pts of +111% · First reported Q4 2024 at $83.95, $858 at Q2 2026 |
| 92 | Sirios Capital Management L PBOSTON, MA · 86 positions · $822M | +5.9% | +9.7% | 6 of 8 | 1.6 | GEVGe Vernova Inc+13 pts of +38% · Held by Q2 2024 at $172, $1,175 at Q2 2026 |
| 93 | Ardsley Advisory Partners LPNorwalk, CT · 130 positions · $921M | +5.9% | +13.2% | 7 of 8 | 1.6 | LITELumentum Holdings Inc+8 pts of +79% · First reported Q4 2024 at $83.95, $858 at Q2 2026 |
| 94 | 683 Capital Management, LLCNEW YORK, NY · 125 positions · $1.0B | +5.9% | +9.9% | 4 of 5 | 1.6 | Wave Life Sciences Ltd+5 pts of +41% · Held by Q2 2024 at $4.99, $5.81 at Q2 2026 |
| 95 | TOMS Capital Investment Management LPNEW YORK, NY · 16 positions · $1.9B | +5.8% | +9.4% | 6 of 8 | 1.6 | STXSeagate Technology Holdings+14 pts of +41% · First reported Q1 2026 at $392, $965 at Q2 2026 |
| 96 | Sandler Capital ManagementNEW YORK, NY · 112 positions · $169M | +5.8% | +7.9% | 6 of 8 | 1.8 | GLWCorning Inc+7 pts of +50% · First reported Q3 2024 at $45.15, $255 at Q2 2026 |
| 97 | Williamson Legacy Group, LLCCARMEL, IN · 75 positions · $201M | +5.8% | +10.6% | 6 of 8 | 1.6 | WDCWestern Digital Corp+9 pts of +62% · Held by Q2 2024 at $75.77, $639 at Q2 2026 |
| 98 | Ashford Capital Management IncWILMINGTON, DE · 107 positions · $933M | +5.8% | +9.4% | 6 of 8 | 1.6 | GSATGlobalstar Inc+8 pts of +21% · First reported Q1 2025 at $20.86, $81.29 at Q2 2026 |
| 99 | Broad Bay Capital Management, LPNew York, NY · 23 positions · $1.1B | +5.8% | +13.0% | 5 of 8 | 1.6 | GSATGlobalstar Inc+7 pts of +36% · First reported Q2 2025 at $23.55, $81.29 at Q2 2026 |
| 100 | Amanah Holdings TrustLONDON, X0 · 20 positions · $1.7B | +5.8% | +67.6% | 3 of 4 | 2.8 | STXSeagate Technology Holdings+46 pts of +172% · First reported Q4 2025 at $275, $965 at Q2 2026 |
Broad winners
Best 12 months among funds with 10+ positions where no one stock made more than half the return| # | Fund | 12 months | vs S&P 500 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Biggest contributor |
|---|---|---|---|---|---|---|---|---|
| 1 | Central Asset Investments & Management Holdings (HK) LtdHONG KONG, K3 · 15 positions · $217M | +251.6% | +230.7 pts | +18% | +1% | +31% | +124% | MUMicron Technology Inc+88 pts of +252% · Held by Q2 2024 at $132, $1,154 at Q2 2026 |
| 2 | Octagon Capital Advisors LPNEW YORK, NY · 26 positions · $1.1B | +221.6% | +200.7 pts | +53% | +37% | +19% | +30% | DNTHDianthus Therapeutics Inc+53 pts of +222% · Held by Q2 2024 at $25.88, $97.48 at Q2 2026 |
| 3 | Foresite Capital Management VI LLCWEST HOLLYWOOD, CA · 23 positions · $643M | +219.6% | +198.8 pts | +57% | +18% | +48% | +16% | ALMSAlumis Inc+70 pts of +220% · First reported Q4 2024 at $7.86, $28.14 at Q2 2026 |
| 4 | Fairmount Funds Management LLCWEST CONSHOHOCKEN, PA · 12 positions · $1.5B | +217.1% | +196.2 pts | +29% | +52% | +23% | +32% | ORKAOruka Therapeutics Inc+48 pts of +217% · First reported Q3 2024 at $24.51, $95.17 at Q2 2026 |
| 5 | TCG Crossover Management, LLCPALO ALTO, CA · 54 positions · $4.2B | +207.8% | +187.0 pts | +64% | +43% | +8% | +22% | ABVXAbivax Sa-Adr+28 pts of +208% · Held by Q2 2024 at $13.22, $133 at Q2 2026 |
| 6 | Venrock Adviser, LLCNEW YORK, NY · 33 positions · $3.3B | +205.9% | +185.1 pts | +27% | +55% | +15% | +35% | Apogee Therapeutics Inc+67 pts of +206% · Held by Q2 2024 at $39.35, $133 at Q2 2026 |
| 7 | Andar Capital Management HK LtdHONG KONG, K3 · 13 positions · $223M | +197.8% | +176.9 pts | +29% | +13% | +17% | +75% | SMTCSemtech Corp+31 pts of +198% · First reported Q2 2025 at $45.14, $162 at Q2 2026 |
| 8 | FengHe Fund Management Pte. Ltd.Singapore, U0 · 18 positions · $1.1B | +196.2% | +175.4 pts | +46% | +21% | +16% | +44% | MKSIMks Inc+28 pts of +196% · First reported Q1 2026 at $230, $445 at Q2 2026 |
| 9 | Talos Eurisko Asset Management LPNEW YORK, NY · 24 positions · $681M | +195.2% | +174.4 pts | +32% | +14% | +22% | +61% | WDCWestern Digital Corp+39 pts of +195% · First reported Q2 2025 at $63.99, $639 at Q2 2026 |
| 10 | Analog Century Management LPNEW YORK, NY · 25 positions · $2.7B | +182.3% | +161.4 pts | +22% | +20% | +22% | +58% | LITELumentum Holdings Inc+23 pts of +182% · First reported Q1 2025 at $62.34, $858 at Q2 2026 |
| 11 | Value Aligned Research Advisors, LLCPRINCETON, NJ · 59 positions · $16.7B | +181.1% | +160.2 pts | +36% | −1% | +22% | +70% | NBISNebius Group NV+26 pts of +181% · First reported Q4 2024 at $27.70, $276 at Q2 2026 |
| 12 | Divisar Capital Management LLCSAN FRANCISCO, CA · 28 positions · $434M | +179.1% | +158.2 pts | +27% | +16% | +29% | +47% | LITELumentum Holdings Inc+36 pts of +179% · Held by Q2 2024 at $50.92, $858 at Q2 2026 |
| 13 | Commodore Capital LPNEW YORK, NY · 33 positions · $1.7B | +176.6% | +155.7 pts | +36% | +24% | +24% | +31% | RLAYRelay Therapeutics Inc+27 pts of +177% · First reported Q2 2025 at $3.46, $18.71 at Q2 2026 |
| 14 | Trivest Advisors LtdHong Kong, K3 · 15 positions · $3.2B | +173.1% | +152.3 pts | +16% | −0% | +16% | +105% | MUMicron Technology Inc+64 pts of +173% · First reported Q1 2025 at $86.89, $1,154 at Q2 2026 |
| 15 | Amanah Holdings TrustLONDON, X0 · 20 positions · $1.7B | +171.9% | +151.1 pts | +29% | −0% | +35% | +57% | STXSeagate Technology Holdings+46 pts of +172% · First reported Q4 2025 at $275, $965 at Q2 2026 |
| 16 | Acuta Capital Partners, LLCREDWOOD CITY, CA · 23 positions · $143M | +168.9% | +148.0 pts | +47% | +43% | +14% | +12% | Cidara Therapeutics Inc+46 pts of +169% · First reported Q4 2024 at $26.88 |
| 17 | Situational Awareness LPSAN FRANCISCO, CA · 23 positions · $20.2B | +164.7% | +143.8 pts | +33% | −17% | +37% | +75% | BEBloom Energy Corp- A+67 pts of +165% · First reported Q4 2025 at $86.89, $303 at Q2 2026 |
| 18 | AIGH Capital Management LLCBALTIMORE, MD · 42 positions · $1.1B | +154.7% | +133.8 pts | +27% | +18% | +32% | +29% | SNDKSandisk Corp+65 pts of +155% · First reported Q3 2025 at $112, $2,274 at Q2 2026 |
| 19 | Saturn V Capital Management LPAUSTIN, TX · 23 positions · $697M | +150.7% | +129.9 pts | +50% | +30% | +9% | +18% | COGTCogent Biosciences Inc+23 pts of +151% · Held by Q2 2024 at $8.43, $38.70 at Q2 2026 |
| 20 | Stempoint Capital LPNEW YORK, NY · 73 positions · $578M | +146.2% | +125.3 pts | +39% | +30% | +9% | +25% | ROIVRoivant Sciences Ltd+12 pts of +146% · Held by Q2 2024 at $10.57, $35.39 at Q2 2026 |
| 21 | Lynx1 Capital Management LPDORADO, PR · 27 positions · $866M | +145.8% | +125.0 pts | +47% | +11% | +13% | +34% | GHRSGh Research PLC+45 pts of +146% · Held by Q2 2024 at $11.66, $26.88 at Q2 2026 |
| 22 | Acorn Capital Advisors, LLCNEW YORK, NY · 20 positions · $366M | +144.0% | +123.2 pts | +42% | +12% | +13% | +35% | CGONCg Oncology Inc+32 pts of +144% · First reported Q4 2024 at $28.68, $71.05 at Q2 2026 |
| 23 | Kynam Capital Management, LPPRINCETON, NJ · 32 positions · $1.8B | +142.4% | +121.6 pts | +35% | +46% | +7% | +15% | COGTCogent Biosciences Inc+26 pts of +142% · Held by Q2 2024 at $8.43, $38.70 at Q2 2026 |
| 24 | Mpm Bioimpact LLCBOSTON, MA · 37 positions · $1.6B | +142.0% | +121.2 pts | +21% | +30% | +14% | +34% | CGEMCullinan Therapeutics Inc+14 pts of +142% · Held by Q2 2024 at $17.44, $18.21 at Q2 2026 |
| 25 | Maple Rock Capital Partners Inc.Toronto, A6 · 51 positions · $5.1B | +140.2% | +119.3 pts | +35% | +16% | +14% | +35% | WDCWestern Digital Corp+61 pts of +140% · Held by Q2 2024 at $75.77, $639 at Q2 2026 |
| 26 | Logos Global Management LPSan Francisco, CA · 68 positions · $2.3B | +139.9% | +119.1 pts | +31% | +41% | +6% | +23% | RVMDRevolution Medicines Inc+35 pts of +140% · Held by Q2 2024 at $38.81, $187 at Q2 2026 |
| 27 | Apis Capital Advisors, LLCNew York, NY · 60 positions · $1.0B | +139.6% | +118.7 pts | +23% | +21% | +16% | +39% | WDCWestern Digital Corp+19 pts of +140% · First reported Q3 2025 at $120, $639 at Q2 2026 |
| 28 | Superstring Capital Management LPNEW YORK, NY · 32 positions · $158M | +139.3% | +118.5 pts | +40% | +33% | +2% | +27% | COGTCogent Biosciences Inc+22 pts of +139% · First reported Q4 2024 at $7.80, $38.70 at Q2 2026 |
| 29 | SanofiParis, I0 · 10 positions · $534M | +136.4% | +115.6 pts | +40% | +18% | +4% | +38% | INBXInhibrx Biosciences Inc+51 pts of +136% · First reported Q4 2024 at $15.40, $94.75 at Q2 2026 |
| 30 | WT Asset Management LtdHONG KONG, K3 · 24 positions · $5.0B | +135.9% | +115.1 pts | +18% | +5% | +17% | +62% | LITELumentum Holdings Inc+25 pts of +136% · First reported Q2 2025 at $95.06, $858 at Q2 2026 |
| 31 | Avidity Partners Management LPDALLAS, TX · 45 positions · $624M | +134.2% | +113.4 pts | +18% | +12% | +40% | +26% | DNTHDianthus Therapeutics Inc+55 pts of +134% · Held by Q2 2024 at $25.88, $97.48 at Q2 2026 |
| 32 | Hel Ved Capital Management LtdCENTRAL, K3 · 63 positions · $710M | +133.2% | +112.4 pts | +17% | −4% | +28% | +63% | SMHVaneck Semiconductor ETF+39 pts of +133% · First reported Q1 2026 at $383, $656 at Q2 2026 |
| 33 | Galaxy Digital Capital Management GP LLCNEW YORK, NY · 51 positions · $167M | +133.0% | +112.2 pts | +46% | −9% | +3% | +71% | RIOTRiot Platforms Inc+23 pts of +133% · First reported Q4 2024 at $10.21, $27.38 at Q2 2026 |
| 34 | Deep Track Capital, LPGREENWICH, CT · 66 positions · $6.8B | +132.9% | +112.0 pts | +31% | +41% | −3% | +30% | GHGuardant Health Inc+15 pts of +133% · Held by Q2 2024 at $28.88, $150 at Q2 2026 |
| 35 | Merck & Co., Inc.RAHWAY, NJ · 13 positions · $526M | +132.6% | +111.7 pts | +6% | +22% | +14% | +58% | MRNAModerna Inc+45 pts of +133% · First reported Q4 2024 at $41.58, $70.03 at Q2 2026 |
| 36 | ARCH Venture Management, LLCCHICAGO, IL · 12 positions · $1.1B | +131.9% | +111.1 pts | +67% | +30% | −8% | +16% | RAPPRapport Therapeutics Inc+36 pts of +132% · Held by Q2 2024 at $23.26, $41.67 at Q2 2026 |
| 37 | Paradigm Biocapital Advisors LPNEW YORK, NY · 28 positions · $5.3B | +130.4% | +109.5 pts | +33% | +25% | +9% | +27% | RVMDRevolution Medicines Inc+44 pts of +130% · Held by Q2 2024 at $38.81, $187 at Q2 2026 |
| 38 | Opaleye Management Inc.BOSTON, MA · 58 positions · $1.1B | +126.9% | +106.0 pts | +41% | +12% | +2% | +40% | LQDALiquidia Corp+35 pts of +127% · Held by Q2 2024 at $12.00, $79.73 at Q2 2026 |
| 39 | Two Seas Capital LPRYE, NY · 37 positions · $2.6B | +123.2% | +102.4 pts | +37% | +13% | +10% | +30% | ROIVRoivant Sciences Ltd+22 pts of +123% · Held by Q2 2024 at $10.57, $35.39 at Q2 2026 |
| 40 | Great Point Partners LLCGreenwich, CT · 37 positions · $424M | +123.1% | +102.3 pts | +37% | +20% | +13% | +21% | Apogee Therapeutics Inc+18 pts of +123% · First reported Q3 2025 at $39.73, $133 at Q2 2026 |
| 41 | Vestal Point Capital, LPNEW YORK, NY · 68 positions · $4.3B | +122.9% | +102.1 pts | +28% | +28% | +11% | +23% | RVMDRevolution Medicines Inc+13 pts of +123% · First reported Q2 2025 at $36.79, $187 at Q2 2026 |
| 42 | Slate Path Capital LPNew York, NY · 40 positions · $7.2B | +121.5% | +100.6 pts | +41% | +16% | −4% | +41% | SNDKSandisk Corp+13 pts of +122% · First reported Q1 2025 at $47.61, $2,274 at Q2 2026 |
| 43 | Johnson & JohnsonNEW BRUNSWICK, NJ · 15 positions · $799M | +121.5% | +100.6 pts | +36% | +14% | +18% | +21% | PTGXProtagonist Therapeutics Inc+47 pts of +121% · Held by Q2 2024 at $34.65, $123 at Q2 2026 |
| 44 | Siren, L.L.C.New York, NY · 115 positions · $4.9B | +121.0% | +100.1 pts | +31% | +25% | +5% | +28% | KYMRKymera Therapeutics Inc+12 pts of +121% · First reported Q3 2024 at $47.33, $115 at Q2 2026 |
| 45 | 5AM Venture Management, LLCSAN FRANCISCO, CA · 16 positions · $288M | +120.9% | +100.0 pts | +29% | +34% | +15% | +11% | TYRATyra Biosciences Inc+12 pts of +121% · Held by Q2 2024 at $15.99, $31.94 at Q2 2026 |
| 46 | Affinity Asset Advisors, LLCNEW YORK, NY · 101 positions · $2.0B | +120.8% | +100.0 pts | +29% | +30% | +7% | +23% | Apogee Therapeutics Inc+14 pts of +121% · Held by Q2 2024 at $39.35, $133 at Q2 2026 |
| 47 | Bain Capital Life Sciences Investors, LLCBoston, MA · 21 positions · $1.7B | +119.0% | +98.1 pts | +56% | +39% | −11% | +13% | Cidara Therapeutics Inc+54 pts of +119% · First reported Q3 2024 at $10.75 |
| 48 | SR One Capital Management, LPRedwood City, CA · 15 positions · $1.0B | +118.7% | +97.9 pts | +44% | +3% | +8% | +36% | MANEVeradermics Inc+36 pts of +119% · First reported Q1 2026 at $63.15, $123 at Q2 2026 |
| 49 | Arosa Capital Management LPMIAMI BEACH, FL · 22 positions · $115M | +116.3% | +95.5 pts | +24% | −2% | +20% | +48% | VICRVicor Corp+38 pts of +116% · First reported Q4 2025 at $110, $380 at Q2 2026 |
| 50 | Silverarc Capital Management, LLCBOSTON, MA · 65 positions · $899M | +116.1% | +95.2 pts | +30% | +28% | +9% | +20% | DNTHDianthus Therapeutics Inc+11 pts of +116% · First reported Q1 2025 at $18.14, $97.48 at Q2 2026 |
| 51 | BIT Capital GmbHBERLIN, 2M · 82 positions · $2.9B | +114.6% | +93.7 pts | +55% | −7% | −13% | +71% | IRENIren Ltd+34 pts of +115% · Held by Q2 2024 at $11.29, $45.73 at Q2 2026 |
| 52 | Avoro Capital Advisors LLCNEW YORK, NY · 26 positions · $11.1B | +112.8% | +91.9 pts | +36% | +25% | +4% | +20% | ARWRArrowhead Pharmaceuticals in+13 pts of +113% · Held by Q2 2024 at $25.99, $81.51 at Q2 2026 |
| 53 | Grand Alliance Asset Management LtdHONG KONG, K3 · 15 positions · $167M | +112.5% | +91.6 pts | +22% | +6% | +4% | +56% | MUMicron Technology Inc+37 pts of +112% · First reported Q1 2025 at $86.89, $1,154 at Q2 2026 |
| 54 | Maytree Asset Management LtdHONG KONG, K3 · 44 positions · $154M | +112.4% | +91.6 pts | +24% | −4% | +14% | +56% | INTCIntel Corp+56 pts of +112% · First reported Q4 2025 at $36.90, $140 at Q2 2026 |
| 55 | CloudAlpha Capital Management Limited/Hong KongHONG KONG, K3 · 24 positions · $1.0B | +111.3% | +90.5 pts | +30% | +7% | +24% | +23% | LITELumentum Holdings Inc+19 pts of +111% · First reported Q4 2024 at $83.95, $858 at Q2 2026 |
| 56 | Exome Asset Management LLCNEW YORK, NY · 52 positions · $162M | +109.9% | +89.1 pts | +27% | +36% | +3% | +18% | COGTCogent Biosciences Inc+13 pts of +110% · First reported Q1 2025 at $5.99, $38.70 at Q2 2026 |
| 57 | DAFNA Capital Management LLCLOS ANGELES, CA · 88 positions · $524M | +109.8% | +88.9 pts | +31% | +19% | +3% | +31% | RVMDRevolution Medicines Inc+34 pts of +110% · Held by Q2 2024 at $38.81, $187 at Q2 2026 |
| 58 | Fcpm III Services B.V.NAARDEN, P7 · 11 positions · $750M | +109.2% | +88.4 pts | +42% | +35% | −5% | +15% | NAMSNewamsterdam Pharma Co NV+45 pts of +109% · Held by Q2 2024 at $19.21, $33.89 at Q2 2026 |
| 59 | Sphera Funds Management Ltd.TEL AVIV, L3 · 97 positions · $699M | +109.2% | +88.3 pts | +29% | +23% | +13% | +17% | TSEMTower Semiconductor Ltd+13 pts of +109% · Held by Q2 2024 at $39.31, $261 at Q2 2026 |
| 60 | Samsara Biocapital, LLCPALO ALTO, CA · 24 positions · $1.2B | +108.9% | +88.0 pts | +59% | +20% | −1% | +11% | ALMSAlumis Inc+28 pts of +109% · First reported Q3 2024 at $10.68, $28.14 at Q2 2026 |
| 61 | Vivo Capital, LLCPalo Alto, CA · 47 positions · $1.1B | +106.5% | +85.7 pts | +22% | +42% | +9% | +10% | Cidara Therapeutics Inc+27 pts of +107% · First reported Q4 2024 at $26.88 |
| 62 | Redmile Group, LLCLARKSPUR, CA · 39 positions · $1.5B | +105.2% | +84.4 pts | +23% | +39% | −1% | +21% | KRYSKrystal Biotech Inc+19 pts of +105% · Held by Q2 2024 at $184, $372 at Q2 2026 |
| 63 | Mhr Fund Management LLCNEW YORK, NY · 11 positions · $1.9B | +103.3% | +82.4 pts | +11% | +13% | +17% | +39% | TSATTelesat Corp+51 pts of +103% · Held by Q2 2024 at $9.10, $50.62 at Q2 2026 |
| 64 | Panoramic Capital, LLCLARKSPUR, CA · 43 positions · $232M | +103.0% | +82.1 pts | +19% | +9% | +9% | +43% | STXSeagate Technology Holdings+36 pts of +103% · First reported Q4 2024 at $86.31, $965 at Q2 2026 |
| 65 | Ikarian Capital, LLCDALLAS, TX · 126 positions · $611M | +102.3% | +81.5 pts | +33% | +34% | +1% | +13% | Cidara Therapeutics Inc+17 pts of +102% · First reported Q4 2024 at $26.88 |
| 66 | Frazier Life Sciences Management, L.P.PALO ALTO, CA · 41 positions · $4.6B | +101.8% | +80.9 pts | +34% | +31% | −5% | +21% | MIRMMirum Pharmaceuticals Inc+21 pts of +102% · Held by Q2 2024 at $34.19, $117 at Q2 2026 |
| 67 | Ariose Capital Management LtdCENTRAL, HONG KONG, K3 · 19 positions · $234M | +101.7% | +80.9 pts | +13% | +11% | −5% | +69% | STXSeagate Technology Holdings+44 pts of +102% · First reported Q1 2026 at $392, $965 at Q2 2026 |
| 68 | Evergreen Quality Fund GP, Ltd.GRAND CAYMAN, E9 · 43 positions · $6.2B | +101.6% | +80.7 pts | +13% | +7% | +7% | +55% | INTCIntel Corp+34 pts of +102% · First reported Q4 2025 at $36.90, $140 at Q2 2026 |
| 69 | Goodlander Investment Management, LLCDALLAS, TX · 15 positions · $331M | +101.3% | +80.4 pts | +16% | +3% | +27% | +32% | FPSForgent Power Solutions-Cl A+19 pts of +101% · First reported Q1 2026 at $29.27, $55.86 at Q2 2026 |
| 70 | California First Leasing CorpNEWPORT BEACH, CA · 34 positions · $471M | +99.2% | +78.3 pts | +8% | +10% | +6% | +58% | MUMicron Technology Inc+34 pts of +99% · Held by Q2 2024 at $132, $1,154 at Q2 2026 |
| 71 | Perceptive Advisors LLCNEW YORK, NY · 101 positions · $6.4B | +97.4% | +76.5 pts | +25% | +25% | +4% | +23% | SYRESpyre Therapeutics Inc+7 pts of +97% · Held by Q2 2024 at $23.51, $88.78 at Q2 2026 |
| 72 | Plustick Management LLCCHARLOTTESVILLE, VA · 23 positions · $236M | +96.1% | +75.2 pts | +44% | +2% | −0% | +34% | APLDApplied Digital Corp+25 pts of +96% · Held by Q2 2024 at $5.95, $37.30 at Q2 2026 |
| 73 | Whitefort Capital Management, LPNEW YORK, NY · 18 positions · $392M | +95.7% | +74.8 pts | +28% | +17% | +1% | +30% | ROIVRoivant Sciences Ltd+28 pts of +96% · Held by Q2 2024 at $10.57, $35.39 at Q2 2026 |
| 74 | Alphabet Inc.Mountain View, CA · 28 positions · $99.1B | +94.8% | +73.9 pts | +20% | +23% | +11% | +19% | PLPlanet Labs Pbc+44 pts of +95% · Held by Q2 2024 at $1.86, $33.13 at Q2 2026 |
| 75 | NEA Management Company, LLCTIMONIUM, MD · 26 positions · $1.6B | +94.2% | +73.3 pts | +38% | +18% | +3% | +17% | TRVITrevi Therapeutics Inc+18 pts of +94% · Held by Q2 2024 at $2.98, $18.65 at Q2 2026 |
| 76 | Sofinnova Investments, Inc.Menlo Park, CA · 53 positions · $1.9B | +93.9% | +73.0 pts | +17% | +34% | +7% | +15% | Astrazeneca Plc-Spons ADR+13 pts of +94% · Held by Q2 2024 at $77.99, $190 at Q2 2026 |
| 77 | Ra Capital Management, L.P.BOSTON, MA · 84 positions · $11.5B | +93.4% | +72.5 pts | +33% | +23% | +2% | +15% | Ascendis Pharma A/S+17 pts of +93% · Held by Q2 2024 at $136, $267 at Q2 2026 |
| 78 | EcoR1 Capital, LLCSan Francisco, CA · 31 positions · $2.0B | +92.0% | +71.2 pts | +33% | +19% | +3% | +18% | ANABAnaptysbio Inc+25 pts of +92% · Held by Q2 2024 at $25.06, $67.50 at Q2 2026 |
| 79 | First Light Asset Management, LLCEdina, MN · 31 positions · $1.6B | +92.0% | +71.1 pts | +22% | +29% | −10% | +35% | AXGNAxogen Inc+22 pts of +92% · Held by Q2 2024 at $7.24, $46.19 at Q2 2026 |
| 80 | AI-Squared Management LtdHONG KONG, K3 · 19 positions · $187M | +91.8% | +71.0 pts | +30% | +0% | −5% | +56% | MUMicron Technology Inc+31 pts of +92% · First reported Q1 2025 at $86.89, $1,154 at Q2 2026 |
| 81 | Tairen Capital LtdHONG KONG, K3 · 44 positions · $1.1B | +91.0% | +70.1 pts | +10% | +2% | +0% | +71% | MUMicron Technology Inc+29 pts of +91% · First reported Q1 2025 at $86.89, $1,154 at Q2 2026 |
| 82 | Soleus Capital Management, L.P.GREENWICH, CT · 97 positions · $2.9B | +90.1% | +69.3 pts | +18% | +28% | −0% | +26% | KRYSKrystal Biotech Inc+16 pts of +90% · Held by Q2 2024 at $184, $372 at Q2 2026 |
| 83 | Harbor Island Capital LLCTopsfield, MA · 16 positions · $376M | +90.1% | +69.2 pts | +17% | +12% | +3% | +41% | AMATApplied Materials Inc+35 pts of +90% · Held by Q2 2024 at $236, $723 at Q2 2026 |
| 84 | Foursixthree Capital LPNEW YORK, NY · 13 positions · $370M | +89.6% | +68.8 pts | +45% | +38% | +2% | −7% | LITELumentum Holdings Inc+25 pts of +90% · First reported Q1 2025 at $62.34, $858 at Q2 2026 |
| 85 | Sectoral Asset Management IncMONTREAL, A8 · 82 positions · $143M | +89.3% | +68.5 pts | +40% | +26% | +1% | +7% | LENZLenz Therapeutics Inc+11 pts of +89% · Held by Q2 2024 at $17.29, $5.68 at Q2 2026 |
| 86 | Casdin Capital, LLCNew York, NY · 43 positions · $2.0B | +88.8% | +67.9 pts | +21% | +28% | −17% | +47% | RVMDRevolution Medicines Inc+39 pts of +89% · Held by Q2 2024 at $38.81, $187 at Q2 2026 |
| 87 | Archon Capital Management LLCSeattle, WA · 43 positions · $246M | +88.0% | +67.1 pts | +22% | +8% | +0% | +43% | BWBabcock & Wilcox Enterpr+13 pts of +88% · First reported Q3 2025 at $2.90, $14.10 at Q2 2026 |
| 88 | Thomist Capital Management, LPHouston, TX · 39 positions · $271M | +87.6% | +66.8 pts | +33% | +10% | +30% | −2% | SDRLSeadrill Limited+13 pts of +88% · First reported Q3 2024 at $39.74, $37.82 at Q2 2026 |
| 89 | Shannon River Fund Management LLCNEW YORK, NY · 37 positions · $1.1B | +87.6% | +66.8 pts | +19% | +7% | −8% | +60% | TSEMTower Semiconductor Ltd+32 pts of +88% · Held by Q2 2024 at $39.31, $261 at Q2 2026 |
| 90 | HERALD INVESTMENT MANAGEMENT LtdLONDON, X0 · 92 positions · $737M | +87.5% | +66.6 pts | +13% | +3% | +1% | +59% | SIMOSilicon Motion Technol-Adr+16 pts of +88% · Held by Q2 2024 at $80.99, $333 at Q2 2026 |
| 91 | HighVista Strategies LLCBOSTON, MA · 147 positions · $439M | +86.6% | +65.7 pts | +18% | +25% | +3% | +23% | COGTCogent Biosciences Inc+4 pts of +87% · Held by Q2 2024 at $8.43, $38.70 at Q2 2026 |
| 92 | Peregrine Investment Management IncTORONTO, A6 · 26 positions · $235M | +86.5% | +65.6 pts | +32% | +8% | −10% | +45% | SITMSitime Corp+14 pts of +86% · First reported Q4 2024 at $215, $746 at Q2 2026 |
| 93 | BlackBarn Capital Partners LPNEW YORK, NY · 17 positions · $402M | +84.6% | +63.7 pts | +19% | +17% | +5% | +27% | ROIVRoivant Sciences Ltd+34 pts of +85% · Held by Q2 2024 at $10.57, $35.39 at Q2 2026 |
| 94 | Kailix Advisors LLCAVENTURA, FL · 11 positions · $104M | +84.0% | +63.1 pts | +11% | +24% | +29% | +3% | CSTMConstellium SE+25 pts of +84% · Held by Q2 2024 at $18.85, $31.87 at Q2 2026 |
| 95 | Sio Capital Management, LLCNEW YORK, NY · 57 positions · $584M | +83.7% | +62.8 pts | +29% | +23% | −2% | +18% | CELCCelcuity Inc+14 pts of +84% · First reported Q3 2025 at $49.40, $105 at Q2 2026 |
| 96 | Paradigm Capital Management Inc/NyALBANY, NY · 115 positions · $3.7B | +83.5% | +62.7 pts | +16% | +5% | +10% | +38% | ONTOOnto Innovation Inc+16 pts of +84% · Held by Q2 2024 at $220, $378 at Q2 2026 |
| 97 | Whale Rock Capital Management LLCBoston, MA · 35 positions · $12.5B | +83.0% | +62.1 pts | +22% | +2% | −1% | +48% | CLSCelestica Inc+10 pts of +83% · Held by Q2 2024 at $57.33, $365 at Q2 2026 |
| 98 | North Growth Management Ltd.VANCOUVER, A1 · 48 positions · $780M | +83.0% | +62.1 pts | +14% | +17% | +11% | +25% | CIENCiena Corp+22 pts of +83% · Held by Q2 2024 at $48.18, $491 at Q2 2026 |
| 99 | Velan Capital Investment Management LPALPHARETTA, GA · 50 positions · $163M | +82.3% | +61.4 pts | +31% | +31% | −1% | +7% | Cidara Therapeutics Inc+26 pts of +82% · First reported Q2 2025 at $48.71 |
| 100 | Orion Resource Partners LPNEW YORK, NY · 24 positions · $219M | +81.0% | +60.1 pts | +39% | +29% | +11% | −9% | AAUCAllied Gold Corp+21 pts of +81% · First reported Q2 2025 at $13.43, $23.76 at Q2 2026 |
All funds
Best 12 months, including funds that won on one stock| # | Fund | 12 months | vs S&P 500 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Biggest contributor |
|---|---|---|---|---|---|---|---|---|
| 1 | BRC Group Holdings, Inc.LOS ANGELES, CA · 35 positions · $433M | +476.3% | +455.4 pts | +68% | +71% | +98% | +1% | BWBabcock & Wilcox Enterpr+447 pts of +476% · Held by Q2 2024 at $1.45, $14.10 at Q2 2026 |
| 2 | Nextech Invest Ltd.Zurich, V8 · 15 positions · $2.1B | +310.3% | +289.4 pts | +27% | +52% | +34% | +58% | RVMDRevolution Medicines Inc+217 pts of +310% · First reported Q1 2025 at $35.36, $187 at Q2 2026 |
| 3 | Central Asset Investments & Management Holdings (HK) LtdHONG KONG, K3 · 15 positions · $217M | +251.6% | +230.7 pts | +18% | +1% | +31% | +124% | MUMicron Technology Inc+88 pts of +252% · Held by Q2 2024 at $132, $1,154 at Q2 2026 |
| 4 | Foresite Capital Management V, LLCWEST HOLLYWOOD, CA · 9 positions · $362M | +250.9% | +230.1 pts | +42% | +37% | +49% | +21% | ALMSAlumis Inc+173 pts of +251% · Held by Q2 2024 at $13.30, $28.14 at Q2 2026 |
| 5 | Octagon Capital Advisors LPNEW YORK, NY · 26 positions · $1.1B | +221.6% | +200.7 pts | +53% | +37% | +19% | +30% | DNTHDianthus Therapeutics Inc+53 pts of +222% · Held by Q2 2024 at $25.88, $97.48 at Q2 2026 |
| 6 | Foresite Capital Management VI LLCWEST HOLLYWOOD, CA · 23 positions · $643M | +219.6% | +198.8 pts | +57% | +18% | +48% | +16% | ALMSAlumis Inc+70 pts of +220% · First reported Q4 2024 at $7.86, $28.14 at Q2 2026 |
| 7 | Fairmount Funds Management LLCWEST CONSHOHOCKEN, PA · 12 positions · $1.5B | +217.1% | +196.2 pts | +29% | +52% | +23% | +32% | ORKAOruka Therapeutics Inc+48 pts of +217% · First reported Q3 2024 at $24.51, $95.17 at Q2 2026 |
| 8 | OCO Capital Partners, L.P.New York, NY · 5 positions · $569M | +215.0% | +194.1 pts | +46% | +28% | +8% | +56% | VSATViasat Inc+193 pts of +215% · First reported Q1 2025 at $10.42, $89.81 at Q2 2026 |
| 9 | TCG Crossover Management, LLCPALO ALTO, CA · 54 positions · $4.2B | +207.8% | +187.0 pts | +64% | +43% | +8% | +22% | ABVXAbivax Sa-Adr+28 pts of +208% · Held by Q2 2024 at $13.22, $133 at Q2 2026 |
| 10 | Venrock Adviser, LLCNEW YORK, NY · 33 positions · $3.3B | +205.9% | +185.1 pts | +27% | +55% | +15% | +35% | Apogee Therapeutics Inc+67 pts of +206% · Held by Q2 2024 at $39.35, $133 at Q2 2026 |
| 11 | Andar Capital Management HK LtdHONG KONG, K3 · 13 positions · $223M | +197.8% | +176.9 pts | +29% | +13% | +17% | +75% | SMTCSemtech Corp+31 pts of +198% · First reported Q2 2025 at $45.14, $162 at Q2 2026 |
| 12 | FengHe Fund Management Pte. Ltd.Singapore, U0 · 18 positions · $1.1B | +196.2% | +175.4 pts | +46% | +21% | +16% | +44% | MKSIMks Inc+28 pts of +196% · First reported Q1 2026 at $230, $445 at Q2 2026 |
| 13 | Talos Eurisko Asset Management LPNEW YORK, NY · 24 positions · $681M | +195.2% | +174.4 pts | +32% | +14% | +22% | +61% | WDCWestern Digital Corp+39 pts of +195% · First reported Q2 2025 at $63.99, $639 at Q2 2026 |
| 14 | Boxer Capital Management, LLCSan Diego, CA · 63 positions · $1.3B | +183.6% | +162.7 pts | +38% | +13% | +35% | +35% | TNGXTango Therapeutics Inc+99 pts of +184% · First reported Q4 2024 at $3.09, $31.26 at Q2 2026 |
| 15 | Analog Century Management LPNEW YORK, NY · 25 positions · $2.7B | +182.3% | +161.4 pts | +22% | +20% | +22% | +58% | LITELumentum Holdings Inc+23 pts of +182% · First reported Q1 2025 at $62.34, $858 at Q2 2026 |
| 16 | Value Aligned Research Advisors, LLCPRINCETON, NJ · 59 positions · $16.7B | +181.1% | +160.2 pts | +36% | −1% | +22% | +70% | NBISNebius Group NV+26 pts of +181% · First reported Q4 2024 at $27.70, $276 at Q2 2026 |
| 17 | Divisar Capital Management LLCSAN FRANCISCO, CA · 28 positions · $434M | +179.1% | +158.2 pts | +27% | +16% | +29% | +47% | LITELumentum Holdings Inc+36 pts of +179% · Held by Q2 2024 at $50.92, $858 at Q2 2026 |
| 18 | Commodore Capital LPNEW YORK, NY · 33 positions · $1.7B | +176.6% | +155.7 pts | +36% | +24% | +24% | +31% | RLAYRelay Therapeutics Inc+27 pts of +177% · First reported Q2 2025 at $3.46, $18.71 at Q2 2026 |
| 19 | Trivest Advisors LtdHong Kong, K3 · 15 positions · $3.2B | +173.1% | +152.3 pts | +16% | −0% | +16% | +105% | MUMicron Technology Inc+64 pts of +173% · First reported Q1 2025 at $86.89, $1,154 at Q2 2026 |
| 20 | Amanah Holdings TrustLONDON, X0 · 20 positions · $1.7B | +171.9% | +151.1 pts | +29% | −0% | +35% | +57% | STXSeagate Technology Holdings+46 pts of +172% · First reported Q4 2025 at $275, $965 at Q2 2026 |
| 21 | PKO BP BANKOWY Universal Pension Society JSCWARSAW, R9 · 13 positions · $350M | +171.2% | +150.3 pts | +15% | +18% | +10% | +83% | MUMicron Technology Inc+131 pts of +171% · First reported Q4 2024 at $84.16, $1,154 at Q2 2026 |
| 22 | Caligan Partners LPNEW YORK, NY · 25 positions · $2.1B | +170.2% | +149.3 pts | +37% | +32% | +4% | +44% | LQDALiquidia Corp+85 pts of +170% · Held by Q2 2024 at $12.00, $79.73 at Q2 2026 |
| 23 | Acuta Capital Partners, LLCREDWOOD CITY, CA · 23 positions · $143M | +168.9% | +148.0 pts | +47% | +43% | +14% | +12% | Cidara Therapeutics Inc+46 pts of +169% · First reported Q4 2024 at $26.88 |
| 24 | venBio Partners LLCSAN FRANCISCO, CA · 7 positions · $519M | +166.9% | +146.0 pts | +35% | +26% | +28% | +22% | ALMSAlumis Inc+91 pts of +167% · Held by Q2 2024 at $13.30, $28.14 at Q2 2026 |
| 25 | Situational Awareness LPSAN FRANCISCO, CA · 23 positions · $20.2B | +164.7% | +143.8 pts | +33% | −17% | +37% | +75% | BEBloom Energy Corp- A+67 pts of +165% · First reported Q4 2025 at $86.89, $303 at Q2 2026 |
| 26 | Brightline Capital Management, LLCMiami, FL · 11 positions · $462M | +156.1% | +135.3 pts | +34% | +17% | +22% | +33% | VSATViasat Inc+86 pts of +156% · First reported Q2 2025 at $14.60, $89.81 at Q2 2026 |
| 27 | Wasserstein Management, L.P.NEW YORK, NY · 5 positions · $240M | +154.9% | +134.0 pts | +16% | +9% | +81% | +12% | CLMTCalumet Inc+129 pts of +155% · First reported Q3 2024 at $17.82, $36.02 at Q2 2026 |
| 28 | AIGH Capital Management LLCBALTIMORE, MD · 42 positions · $1.1B | +154.7% | +133.8 pts | +27% | +18% | +32% | +29% | SNDKSandisk Corp+65 pts of +155% · First reported Q3 2025 at $112, $2,274 at Q2 2026 |
| 29 | Saturn V Capital Management LPAUSTIN, TX · 23 positions · $697M | +150.7% | +129.9 pts | +50% | +30% | +9% | +18% | COGTCogent Biosciences Inc+23 pts of +151% · Held by Q2 2024 at $8.43, $38.70 at Q2 2026 |
| 30 | Stempoint Capital LPNEW YORK, NY · 73 positions · $578M | +146.2% | +125.3 pts | +39% | +30% | +9% | +25% | ROIVRoivant Sciences Ltd+12 pts of +146% · Held by Q2 2024 at $10.57, $35.39 at Q2 2026 |
| 31 | Lynx1 Capital Management LPDORADO, PR · 27 positions · $866M | +145.8% | +125.0 pts | +47% | +11% | +13% | +34% | GHRSGh Research PLC+45 pts of +146% · Held by Q2 2024 at $11.66, $26.88 at Q2 2026 |
| 32 | Atlas Venture Life Science Advisors, LLCCAMBRIDGE, MA · 7 positions · $881M | +145.4% | +124.5 pts | +29% | +37% | +9% | +28% | KYMRKymera Therapeutics Inc+70 pts of +145% · Held by Q2 2024 at $29.85, $115 at Q2 2026 |
| 33 | Patient Square Capital LPMENLO PARK, CA · 23 positions · $646M | +144.8% | +123.9 pts | +34% | +36% | +15% | +17% | ROIVRoivant Sciences Ltd+89 pts of +145% · Held by Q2 2024 at $10.57, $35.39 at Q2 2026 |
| 34 | Acorn Capital Advisors, LLCNEW YORK, NY · 20 positions · $366M | +144.0% | +123.2 pts | +42% | +12% | +13% | +35% | CGONCg Oncology Inc+32 pts of +144% · First reported Q4 2024 at $28.68, $71.05 at Q2 2026 |
| 35 | Credit Capital Investments LLCLIVINGSTON, NJ · 42 positions · $175M | +143.2% | +122.3 pts | +20% | +18% | +6% | +61% | MUMicron Technology Inc+86 pts of +143% · Held by Q2 2024 at $132, $1,154 at Q2 2026 |
| 36 | Kynam Capital Management, LPPRINCETON, NJ · 32 positions · $1.8B | +142.4% | +121.6 pts | +35% | +46% | +7% | +15% | COGTCogent Biosciences Inc+26 pts of +142% · Held by Q2 2024 at $8.43, $38.70 at Q2 2026 |
| 37 | Mpm Bioimpact LLCBOSTON, MA · 37 positions · $1.6B | +142.0% | +121.2 pts | +21% | +30% | +14% | +34% | CGEMCullinan Therapeutics Inc+14 pts of +142% · Held by Q2 2024 at $17.44, $18.21 at Q2 2026 |
| 38 | Redwood Capital Management, LLCNew York, NY · 24 positions · $922M | +141.7% | +120.8 pts | +83% | +21% | −7% | +18% | ECHOEchostar Corp-A+113 pts of +142% · Held by Q2 2024 at $17.81, $102 at Q2 2026 |
| 39 | QVT Financial LPNew York, NY · 70 positions · $1.5B | +141.6% | +120.7 pts | +33% | +27% | +16% | +23% | ROIVRoivant Sciences Ltd+107 pts of +142% · Held by Q2 2024 at $10.57, $35.39 at Q2 2026 |
| 40 | Maple Rock Capital Partners Inc.Toronto, A6 · 51 positions · $5.1B | +140.2% | +119.3 pts | +35% | +16% | +14% | +35% | WDCWestern Digital Corp+61 pts of +140% · Held by Q2 2024 at $75.77, $639 at Q2 2026 |
| 41 | Logos Global Management LPSan Francisco, CA · 68 positions · $2.3B | +139.9% | +119.1 pts | +31% | +41% | +6% | +23% | RVMDRevolution Medicines Inc+35 pts of +140% · Held by Q2 2024 at $38.81, $187 at Q2 2026 |
| 42 | Apis Capital Advisors, LLCNew York, NY · 60 positions · $1.0B | +139.6% | +118.7 pts | +23% | +21% | +16% | +39% | WDCWestern Digital Corp+19 pts of +140% · First reported Q3 2025 at $120, $639 at Q2 2026 |
| 43 | Superstring Capital Management LPNEW YORK, NY · 32 positions · $158M | +139.3% | +118.5 pts | +40% | +33% | +2% | +27% | COGTCogent Biosciences Inc+22 pts of +139% · First reported Q4 2024 at $7.80, $38.70 at Q2 2026 |
| 44 | Findell Capital Management LLCNew York, NY · 12 positions · $607M | +138.8% | +117.9 pts | +15% | +35% | −9% | +69% | LQDALiquidia Corp+100 pts of +139% · Held by Q2 2024 at $12.00, $79.73 at Q2 2026 |
| 45 | Gendell Jeffrey LGreenwich, CT · 103 positions · $11.1B | +137.6% | +116.8 pts | +33% | +2% | +21% | +44% | IESCIes Holdings Inc+109 pts of +138% · Held by Q2 2024 at $139, $735 at Q2 2026 |
| 46 | DCF Advisers, LLCMOUNT PLEASANT, SC · 80 positions · $382M | +137.3% | +116.4 pts | +21% | +21% | −0% | +62% | MUMicron Technology Inc+90 pts of +137% · Held by Q2 2024 at $132, $1,154 at Q2 2026 |
| 47 | SanofiParis, I0 · 10 positions · $534M | +136.4% | +115.6 pts | +40% | +18% | +4% | +38% | INBXInhibrx Biosciences Inc+51 pts of +136% · First reported Q4 2024 at $15.40, $94.75 at Q2 2026 |
| 48 | WT Asset Management LtdHONG KONG, K3 · 24 positions · $5.0B | +135.9% | +115.1 pts | +18% | +5% | +17% | +62% | LITELumentum Holdings Inc+25 pts of +136% · First reported Q2 2025 at $95.06, $858 at Q2 2026 |
| 49 | Avidity Partners Management LPDALLAS, TX · 45 positions · $624M | +134.2% | +113.4 pts | +18% | +12% | +40% | +26% | DNTHDianthus Therapeutics Inc+55 pts of +134% · Held by Q2 2024 at $25.88, $97.48 at Q2 2026 |
| 50 | Hel Ved Capital Management LtdCENTRAL, K3 · 63 positions · $710M | +133.2% | +112.4 pts | +17% | −4% | +28% | +63% | SMHVaneck Semiconductor ETF+39 pts of +133% · First reported Q1 2026 at $383, $656 at Q2 2026 |
| 51 | Galaxy Digital Capital Management GP LLCNEW YORK, NY · 51 positions · $167M | +133.0% | +112.2 pts | +46% | −9% | +3% | +71% | RIOTRiot Platforms Inc+23 pts of +133% · First reported Q4 2024 at $10.21, $27.38 at Q2 2026 |
| 52 | Deep Track Capital, LPGREENWICH, CT · 66 positions · $6.8B | +132.9% | +112.0 pts | +31% | +41% | −3% | +30% | GHGuardant Health Inc+15 pts of +133% · Held by Q2 2024 at $28.88, $150 at Q2 2026 |
| 53 | Merck & Co., Inc.RAHWAY, NJ · 13 positions · $526M | +132.6% | +111.7 pts | +6% | +22% | +14% | +58% | MRNAModerna Inc+45 pts of +133% · First reported Q4 2024 at $41.58, $70.03 at Q2 2026 |
| 54 | Lunate Capital LtdAL MARYAH ISLAND, ABU DHABI, C0 · 10 positions · $196M | +132.2% | +111.3 pts | +11% | +31% | +6% | +51% | RVMDRevolution Medicines Inc+133 pts of +132% · First reported Q1 2025 at $35.36, $187 at Q2 2026 |
| 55 | ARCH Venture Management, LLCCHICAGO, IL · 12 positions · $1.1B | +131.9% | +111.1 pts | +67% | +30% | −8% | +16% | RAPPRapport Therapeutics Inc+36 pts of +132% · Held by Q2 2024 at $23.26, $41.67 at Q2 2026 |
| 56 | Paradigm Biocapital Advisors LPNEW YORK, NY · 28 positions · $5.3B | +130.4% | +109.5 pts | +33% | +25% | +9% | +27% | RVMDRevolution Medicines Inc+44 pts of +130% · Held by Q2 2024 at $38.81, $187 at Q2 2026 |
| 57 | Scoggin Management LPNEW YORK, NY · 48 positions · $423M | +129.5% | +108.6 pts | +39% | −0% | +5% | +58% | WULFTerawulf Inc+74 pts of +130% · Held by Q2 2024 at $4.45, $24.70 at Q2 2026 |
| 58 | Madison Avenue Partners, LPNEW YORK, NY · 25 positions · $2.3B | +129.1% | +108.2 pts | +28% | +27% | +22% | +16% | SNDKSandisk Corp+76 pts of +129% · First reported Q2 2025 at $45.35, $2,274 at Q2 2026 |
| 59 | Foresite Capital Management IV, LLCWEST HOLLYWOOD, CA · 6 positions · $290M | +129.0% | +108.2 pts | +59% | +22% | −2% | +20% | PHVSPharvaris NV+64 pts of +129% · Held by Q2 2024 at $18.80, $34.58 at Q2 2026 |
| 60 | Broad Peak Investment Advisers Pte LtdSINGAPORE, U0 · 21 positions · $544M | +127.7% | +106.8 pts | +33% | +37% | +0% | +25% | LITELumentum Holdings Inc+68 pts of +128% · First reported Q2 2025 at $95.06, $858 at Q2 2026 |
| 61 | Opaleye Management Inc.BOSTON, MA · 58 positions · $1.1B | +126.9% | +106.0 pts | +41% | +12% | +2% | +40% | LQDALiquidia Corp+35 pts of +127% · Held by Q2 2024 at $12.00, $79.73 at Q2 2026 |
| 62 | Tao Capital Management LPSAN FRANCISCO, CA · 6 positions · $1.9B | +125.2% | +104.3 pts | +19% | +1% | +2% | +82% | TWSTTwist Bioscience Corp+59 pts of +125% · Held by Q2 2024 at $49.28, $103 at Q2 2026 |
| 63 | Decheng Capital LLCMENLO PARK, CA · 14 positions · $732M | +124.9% | +104.0 pts | +50% | +35% | −2% | +13% | CGONCg Oncology Inc+81 pts of +125% · Held by Q2 2024 at $31.57, $71.05 at Q2 2026 |
| 64 | Two Seas Capital LPRYE, NY · 37 positions · $2.6B | +123.2% | +102.4 pts | +37% | +13% | +10% | +30% | ROIVRoivant Sciences Ltd+22 pts of +123% · Held by Q2 2024 at $10.57, $35.39 at Q2 2026 |
| 65 | Great Point Partners LLCGreenwich, CT · 37 positions · $424M | +123.1% | +102.3 pts | +37% | +20% | +13% | +21% | Apogee Therapeutics Inc+18 pts of +123% · First reported Q3 2025 at $39.73, $133 at Q2 2026 |
| 66 | Vestal Point Capital, LPNEW YORK, NY · 68 positions · $4.3B | +122.9% | +102.1 pts | +28% | +28% | +11% | +23% | RVMDRevolution Medicines Inc+13 pts of +123% · First reported Q2 2025 at $36.79, $187 at Q2 2026 |
| 67 | Slate Path Capital LPNew York, NY · 40 positions · $7.2B | +121.5% | +100.6 pts | +41% | +16% | −4% | +41% | SNDKSandisk Corp+13 pts of +122% · First reported Q1 2025 at $47.61, $2,274 at Q2 2026 |
| 68 | Johnson & JohnsonNEW BRUNSWICK, NJ · 15 positions · $799M | +121.5% | +100.6 pts | +36% | +14% | +18% | +21% | PTGXProtagonist Therapeutics Inc+47 pts of +121% · Held by Q2 2024 at $34.65, $123 at Q2 2026 |
| 69 | Siren, L.L.C.New York, NY · 115 positions · $4.9B | +121.0% | +100.1 pts | +31% | +25% | +5% | +28% | KYMRKymera Therapeutics Inc+12 pts of +121% · First reported Q3 2024 at $47.33, $115 at Q2 2026 |
| 70 | 5AM Venture Management, LLCSAN FRANCISCO, CA · 16 positions · $288M | +120.9% | +100.0 pts | +29% | +34% | +15% | +11% | TYRATyra Biosciences Inc+12 pts of +121% · Held by Q2 2024 at $15.99, $31.94 at Q2 2026 |
| 71 | Affinity Asset Advisors, LLCNEW YORK, NY · 101 positions · $2.0B | +120.8% | +100.0 pts | +29% | +30% | +7% | +23% | Apogee Therapeutics Inc+14 pts of +121% · Held by Q2 2024 at $39.35, $133 at Q2 2026 |
| 72 | Bain Capital Life Sciences Investors, LLCBoston, MA · 21 positions · $1.7B | +119.0% | +98.1 pts | +56% | +39% | −11% | +13% | Cidara Therapeutics Inc+54 pts of +119% · First reported Q3 2024 at $10.75 |
| 73 | SR One Capital Management, LPRedwood City, CA · 15 positions · $1.0B | +118.7% | +97.9 pts | +44% | +3% | +8% | +36% | MANEVeradermics Inc+36 pts of +119% · First reported Q1 2026 at $63.15, $123 at Q2 2026 |
| 74 | Arosa Capital Management LPMIAMI BEACH, FL · 22 positions · $115M | +116.3% | +95.5 pts | +24% | −2% | +20% | +48% | VICRVicor Corp+38 pts of +116% · First reported Q4 2025 at $110, $380 at Q2 2026 |
| 75 | Nvp Associates, LLCMENLO PARK, CA · 7 positions · $328M | +116.2% | +95.4 pts | +17% | +28% | −11% | +62% | MBXMbx Biosciences Inc+67 pts of +116% · First reported Q3 2024 at $25.98, $55.20 at Q2 2026 |
| 76 | Silverarc Capital Management, LLCBOSTON, MA · 65 positions · $899M | +116.1% | +95.2 pts | +30% | +28% | +9% | +20% | DNTHDianthus Therapeutics Inc+11 pts of +116% · First reported Q1 2025 at $18.14, $97.48 at Q2 2026 |
| 77 | BIT Capital GmbHBERLIN, 2M · 82 positions · $2.9B | +114.6% | +93.7 pts | +55% | −7% | −13% | +71% | IRENIren Ltd+34 pts of +115% · Held by Q2 2024 at $11.29, $45.73 at Q2 2026 |
| 78 | Avoro Capital Advisors LLCNEW YORK, NY · 26 positions · $11.1B | +112.8% | +91.9 pts | +36% | +25% | +4% | +20% | ARWRArrowhead Pharmaceuticals in+13 pts of +113% · Held by Q2 2024 at $25.99, $81.51 at Q2 2026 |
| 79 | Monarch Alternative Capital LPNew York, NY · 6 positions · $516M | +112.5% | +91.6 pts | +87% | +26% | −1% | −9% | VISNVistance Networks Inc+63 pts of +112% · First reported Q3 2024 at $6.11, $12.78 at Q2 2026 |
| 80 | Grand Alliance Asset Management LtdHONG KONG, K3 · 15 positions · $167M | +112.5% | +91.6 pts | +22% | +6% | +4% | +56% | MUMicron Technology Inc+37 pts of +112% · First reported Q1 2025 at $86.89, $1,154 at Q2 2026 |
| 81 | Maytree Asset Management LtdHONG KONG, K3 · 44 positions · $154M | +112.4% | +91.6 pts | +24% | −4% | +14% | +56% | INTCIntel Corp+56 pts of +112% · First reported Q4 2025 at $36.90, $140 at Q2 2026 |
| 82 | CloudAlpha Capital Management Limited/Hong KongHONG KONG, K3 · 24 positions · $1.0B | +111.3% | +90.5 pts | +30% | +7% | +24% | +23% | LITELumentum Holdings Inc+19 pts of +111% · First reported Q4 2024 at $83.95, $858 at Q2 2026 |
| 83 | Exome Asset Management LLCNEW YORK, NY · 52 positions · $162M | +109.9% | +89.1 pts | +27% | +36% | +3% | +18% | COGTCogent Biosciences Inc+13 pts of +110% · First reported Q1 2025 at $5.99, $38.70 at Q2 2026 |
| 84 | DAFNA Capital Management LLCLOS ANGELES, CA · 88 positions · $524M | +109.8% | +88.9 pts | +31% | +19% | +3% | +31% | RVMDRevolution Medicines Inc+34 pts of +110% · Held by Q2 2024 at $38.81, $187 at Q2 2026 |
| 85 | Fcpm III Services B.V.NAARDEN, P7 · 11 positions · $750M | +109.2% | +88.4 pts | +42% | +35% | −5% | +15% | NAMSNewamsterdam Pharma Co NV+45 pts of +109% · Held by Q2 2024 at $19.21, $33.89 at Q2 2026 |
| 86 | Sphera Funds Management Ltd.TEL AVIV, L3 · 97 positions · $699M | +109.2% | +88.3 pts | +29% | +23% | +13% | +17% | TSEMTower Semiconductor Ltd+13 pts of +109% · Held by Q2 2024 at $39.31, $261 at Q2 2026 |
| 87 | Samsara Biocapital, LLCPALO ALTO, CA · 24 positions · $1.2B | +108.9% | +88.0 pts | +59% | +20% | −1% | +11% | ALMSAlumis Inc+28 pts of +109% · First reported Q3 2024 at $10.68, $28.14 at Q2 2026 |
| 88 | Flat Footed LLCWILSON, WY · 20 positions · $577M | +107.6% | +86.7 pts | +19% | +13% | +24% | +25% | DHCDiversified Healthcare Trust+56 pts of +108% · Held by Q2 2024 at $3.05, $9.30 at Q2 2026 |
| 89 | Vivo Capital, LLCPalo Alto, CA · 47 positions · $1.1B | +106.5% | +85.7 pts | +22% | +42% | +9% | +10% | Cidara Therapeutics Inc+27 pts of +107% · First reported Q4 2024 at $26.88 |
| 90 | BML Capital Management, LLCZIONSVILLE, IN · 15 positions · $175M | +106.2% | +85.3 pts | +10% | +30% | +23% | +17% | ACRSAclaris Therapeutics Inc+64 pts of +106% · Held by Q2 2024 at $1.10, $5.29 at Q2 2026 |
| 91 | Redmile Group, LLCLARKSPUR, CA · 39 positions · $1.5B | +105.2% | +84.4 pts | +23% | +39% | −1% | +21% | KRYSKrystal Biotech Inc+19 pts of +105% · Held by Q2 2024 at $184, $372 at Q2 2026 |
| 92 | Mhr Fund Management LLCNEW YORK, NY · 11 positions · $1.9B | +103.3% | +82.4 pts | +11% | +13% | +17% | +39% | TSATTelesat Corp+51 pts of +103% · Held by Q2 2024 at $9.10, $50.62 at Q2 2026 |
| 93 | Panoramic Capital, LLCLARKSPUR, CA · 43 positions · $232M | +103.0% | +82.1 pts | +19% | +9% | +9% | +43% | STXSeagate Technology Holdings+36 pts of +103% · First reported Q4 2024 at $86.31, $965 at Q2 2026 |
| 94 | Mubadala Investment Co PJSCAbu Dhabi, C0 · 72 positions · $34.8B | +102.5% | +81.6 pts | −5% | −4% | +24% | +80% | GFSGlobalfoundries Inc+103 pts of +102% · Held by Q2 2024 at $50.56, $82.41 at Q2 2026 |
| 95 | Ikarian Capital, LLCDALLAS, TX · 126 positions · $611M | +102.3% | +81.5 pts | +33% | +34% | +1% | +13% | Cidara Therapeutics Inc+17 pts of +102% · First reported Q4 2024 at $26.88 |
| 96 | Frazier Life Sciences Management, L.P.PALO ALTO, CA · 41 positions · $4.6B | +101.8% | +80.9 pts | +34% | +31% | −5% | +21% | MIRMMirum Pharmaceuticals Inc+21 pts of +102% · Held by Q2 2024 at $34.19, $117 at Q2 2026 |
| 97 | Ariose Capital Management LtdCENTRAL, HONG KONG, K3 · 19 positions · $234M | +101.7% | +80.9 pts | +13% | +11% | −5% | +69% | STXSeagate Technology Holdings+44 pts of +102% · First reported Q1 2026 at $392, $965 at Q2 2026 |
| 98 | Evergreen Quality Fund GP, Ltd.GRAND CAYMAN, E9 · 43 positions · $6.2B | +101.6% | +80.7 pts | +13% | +7% | +7% | +55% | INTCIntel Corp+34 pts of +102% · First reported Q4 2025 at $36.90, $140 at Q2 2026 |
| 99 | Goodlander Investment Management, LLCDALLAS, TX · 15 positions · $331M | +101.3% | +80.4 pts | +16% | +3% | +27% | +32% | FPSForgent Power Solutions-Cl A+19 pts of +101% · First reported Q1 2026 at $29.27, $55.86 at Q2 2026 |
| 100 | Atalan Capital Partners, LPNEW YORK, NY · 9 positions · $1.6B | +100.5% | +79.7 pts | +16% | +6% | +4% | +57% | STXSeagate Technology Holdings+62 pts of +101% · First reported Q2 2025 at $144, $965 at Q2 2026 |
| 101 | Blue Water Life Science Advisors, LPLARKSPUR, CA · 9 positions · $159M | +100.4% | +79.6 pts | +5% | +30% | −12% | +69% | GHGuardant Health Inc+30 pts of +100% · Held by Q2 2024 at $28.88, $150 at Q2 2026 |
| 102 | California First Leasing CorpNEWPORT BEACH, CA · 34 positions · $471M | +99.2% | +78.3 pts | +8% | +10% | +6% | +58% | MUMicron Technology Inc+34 pts of +99% · Held by Q2 2024 at $132, $1,154 at Q2 2026 |
| 103 | Oak Grove Capital LLCHolderness, NH · 97 positions · $1.4B | +98.7% | +77.8 pts | +13% | +10% | +3% | +54% | MUMicron Technology Inc+53 pts of +99% · Held by Q2 2024 at $132, $1,154 at Q2 2026 |
| 104 | Four Tree Island Advisory LLCPORTSMOUTH, NH · 24 positions · $303M | +98.4% | +77.5 pts | +11% | +13% | +7% | +47% | LRCXLam Research Corp+53 pts of +98% · First reported Q4 2024 at $72.23, $433 at Q2 2026 |
| 105 | Perceptive Advisors LLCNEW YORK, NY · 101 positions · $6.4B | +97.4% | +76.5 pts | +25% | +25% | +4% | +23% | SYRESpyre Therapeutics Inc+7 pts of +97% · Held by Q2 2024 at $23.51, $88.78 at Q2 2026 |
| 106 | Plustick Management LLCCHARLOTTESVILLE, VA · 23 positions · $236M | +96.1% | +75.2 pts | +44% | +2% | −0% | +34% | APLDApplied Digital Corp+25 pts of +96% · Held by Q2 2024 at $5.95, $37.30 at Q2 2026 |
| 107 | Rakuten Group, Inc.SETAGAYA-KU, M0 · 5 positions · $1.4B | +96.0% | +75.2 pts | +9% | +48% | +14% | +7% | ASTSAst Spacemobile Inc+92 pts of +96% · First reported Q1 2025 at $22.74, $88.86 at Q2 2026 |
| 108 | Whitefort Capital Management, LPNEW YORK, NY · 18 positions · $392M | +95.7% | +74.8 pts | +28% | +17% | +1% | +30% | ROIVRoivant Sciences Ltd+28 pts of +96% · Held by Q2 2024 at $10.57, $35.39 at Q2 2026 |
| 109 | Alphabet Inc.Mountain View, CA · 28 positions · $99.1B | +94.8% | +73.9 pts | +20% | +23% | +11% | +19% | PLPlanet Labs Pbc+44 pts of +95% · Held by Q2 2024 at $1.86, $33.13 at Q2 2026 |
| 110 | NEA Management Company, LLCTIMONIUM, MD · 26 positions · $1.6B | +94.2% | +73.3 pts | +38% | +18% | +3% | +17% | TRVITrevi Therapeutics Inc+18 pts of +94% · Held by Q2 2024 at $2.98, $18.65 at Q2 2026 |
| 111 | Sofinnova Investments, Inc.Menlo Park, CA · 53 positions · $1.9B | +93.9% | +73.0 pts | +17% | +34% | +7% | +15% | Astrazeneca Plc-Spons ADR+13 pts of +94% · Held by Q2 2024 at $77.99, $190 at Q2 2026 |
| 112 | Peconic Partners LLCNEW YORK, NY · 7 positions · $7.5B | +93.8% | +72.9 pts | +13% | +7% | +20% | +34% | PWRQuanta Services Inc+47 pts of +94% · Held by Q2 2024 at $254, $720 at Q2 2026 |
| 113 | Enavate Sciences Gp, LLCNew York, NY · 7 positions · $345M | +93.5% | +72.7 pts | +68% | +54% | −25% | −1% | SIONSionna Therapeutics Inc+36 pts of +94% · First reported Q1 2025 at $10.46, $43.99 at Q2 2026 |
| 114 | Ra Capital Management, L.P.BOSTON, MA · 84 positions · $11.5B | +93.4% | +72.5 pts | +33% | +23% | +2% | +15% | Ascendis Pharma A/S+17 pts of +93% · Held by Q2 2024 at $136, $267 at Q2 2026 |
| 115 | Aisling Capital Management LPNEW YORK, NY · 14 positions · $472M | +92.1% | +71.3 pts | +24% | +48% | −2% | +6% | BBIOBridgebio Pharma Inc+58 pts of +92% · Held by Q2 2024 at $25.33, $74.48 at Q2 2026 |
| 116 | EcoR1 Capital, LLCSan Francisco, CA · 31 positions · $2.0B | +92.0% | +71.2 pts | +33% | +19% | +3% | +18% | ANABAnaptysbio Inc+25 pts of +92% · Held by Q2 2024 at $25.06, $67.50 at Q2 2026 |
| 117 | First Light Asset Management, LLCEdina, MN · 31 positions · $1.6B | +92.0% | +71.1 pts | +22% | +29% | −10% | +35% | AXGNAxogen Inc+22 pts of +92% · Held by Q2 2024 at $7.24, $46.19 at Q2 2026 |
| 118 | AI-Squared Management LtdHONG KONG, K3 · 19 positions · $187M | +91.8% | +71.0 pts | +30% | +0% | −5% | +56% | MUMicron Technology Inc+31 pts of +92% · First reported Q1 2025 at $86.89, $1,154 at Q2 2026 |
| 119 | Pennant Select, LLCSummit, NJ · 15 positions · $225M | +91.0% | +70.2 pts | +44% | +19% | +1% | +10% | ECHOEchostar Corp-A+55 pts of +91% · Held by Q2 2024 at $17.81, $102 at Q2 2026 |
| 120 | Tairen Capital LtdHONG KONG, K3 · 44 positions · $1.1B | +91.0% | +70.1 pts | +10% | +2% | +0% | +71% | MUMicron Technology Inc+29 pts of +91% · First reported Q1 2025 at $86.89, $1,154 at Q2 2026 |
| 121 | Highland Peak Capital, LLCOLD GREENWICH, CT · 13 positions · $344M | +90.1% | +69.3 pts | +15% | +5% | +1% | +56% | SIMOSilicon Motion Technol-Adr+59 pts of +90% · First reported Q2 2025 at $75.17, $333 at Q2 2026 |
| 122 | Soleus Capital Management, L.P.GREENWICH, CT · 97 positions · $2.9B | +90.1% | +69.3 pts | +18% | +28% | −0% | +26% | KRYSKrystal Biotech Inc+16 pts of +90% · Held by Q2 2024 at $184, $372 at Q2 2026 |
| 123 | Harbor Island Capital LLCTopsfield, MA · 16 positions · $376M | +90.1% | +69.2 pts | +17% | +12% | +3% | +41% | AMATApplied Materials Inc+35 pts of +90% · Held by Q2 2024 at $236, $723 at Q2 2026 |
| 124 | Foursixthree Capital LPNEW YORK, NY · 13 positions · $370M | +89.6% | +68.8 pts | +45% | +38% | +2% | −7% | LITELumentum Holdings Inc+25 pts of +90% · First reported Q1 2025 at $62.34, $858 at Q2 2026 |
| 125 | Sectoral Asset Management IncMONTREAL, A8 · 82 positions · $143M | +89.3% | +68.5 pts | +40% | +26% | +1% | +7% | LENZLenz Therapeutics Inc+11 pts of +89% · Held by Q2 2024 at $17.29, $5.68 at Q2 2026 |
| 126 | Alethea Capital Management, LLCMERCER ISLAND, WA · 41 positions · $241M | +89.0% | +68.2 pts | +16% | +36% | −8% | +29% | AXSMAxsome Therapeutics Inc+70 pts of +89% · Held by Q2 2024 at $80.50, $245 at Q2 2026 |
| 127 | Casdin Capital, LLCNew York, NY · 43 positions · $2.0B | +88.8% | +67.9 pts | +21% | +28% | −17% | +47% | RVMDRevolution Medicines Inc+39 pts of +89% · Held by Q2 2024 at $38.81, $187 at Q2 2026 |
| 128 | Archon Capital Management LLCSeattle, WA · 43 positions · $246M | +88.0% | +67.1 pts | +22% | +8% | +0% | +43% | BWBabcock & Wilcox Enterpr+13 pts of +88% · First reported Q3 2025 at $2.90, $14.10 at Q2 2026 |
| 129 | Thomist Capital Management, LPHouston, TX · 39 positions · $271M | +87.6% | +66.8 pts | +33% | +10% | +30% | −2% | SDRLSeadrill Limited+13 pts of +88% · First reported Q3 2024 at $39.74, $37.82 at Q2 2026 |
| 130 | Shannon River Fund Management LLCNEW YORK, NY · 37 positions · $1.1B | +87.6% | +66.8 pts | +19% | +7% | −8% | +60% | TSEMTower Semiconductor Ltd+32 pts of +88% · Held by Q2 2024 at $39.31, $261 at Q2 2026 |
| 131 | HERALD INVESTMENT MANAGEMENT LtdLONDON, X0 · 92 positions · $737M | +87.5% | +66.6 pts | +13% | +3% | +1% | +59% | SIMOSilicon Motion Technol-Adr+16 pts of +88% · Held by Q2 2024 at $80.99, $333 at Q2 2026 |
| 132 | Flagship Pioneering, LLCCAMBRIDGE, MA · 5 positions · $1.5B | +86.7% | +65.9 pts | +9% | +11% | +17% | +33% | MRNAModerna Inc+51 pts of +87% · Held by Q2 2024 at $119, $70.03 at Q2 2026 |
| 133 | HighVista Strategies LLCBOSTON, MA · 147 positions · $439M | +86.6% | +65.7 pts | +18% | +25% | +3% | +23% | COGTCogent Biosciences Inc+4 pts of +87% · Held by Q2 2024 at $8.43, $38.70 at Q2 2026 |
| 134 | Peregrine Investment Management IncTORONTO, A6 · 26 positions · $235M | +86.5% | +65.6 pts | +32% | +8% | −10% | +45% | SITMSitime Corp+14 pts of +86% · First reported Q4 2024 at $215, $746 at Q2 2026 |
| 135 | BlackBarn Capital Partners LPNEW YORK, NY · 17 positions · $402M | +84.6% | +63.7 pts | +19% | +17% | +5% | +27% | ROIVRoivant Sciences Ltd+34 pts of +85% · Held by Q2 2024 at $10.57, $35.39 at Q2 2026 |
| 136 | Kailix Advisors LLCAVENTURA, FL · 11 positions · $104M | +84.0% | +63.1 pts | +11% | +24% | +29% | +3% | CSTMConstellium SE+25 pts of +84% · Held by Q2 2024 at $18.85, $31.87 at Q2 2026 |
| 137 | Sio Capital Management, LLCNEW YORK, NY · 57 positions · $584M | +83.7% | +62.8 pts | +29% | +23% | −2% | +18% | CELCCelcuity Inc+14 pts of +84% · First reported Q3 2025 at $49.40, $105 at Q2 2026 |
| 138 | Paradigm Capital Management Inc/NyALBANY, NY · 115 positions · $3.7B | +83.5% | +62.7 pts | +16% | +5% | +10% | +38% | ONTOOnto Innovation Inc+16 pts of +84% · Held by Q2 2024 at $220, $378 at Q2 2026 |
| 139 | Whale Rock Capital Management LLCBoston, MA · 35 positions · $12.5B | +83.0% | +62.1 pts | +22% | +2% | −1% | +48% | CLSCelestica Inc+10 pts of +83% · Held by Q2 2024 at $57.33, $365 at Q2 2026 |
| 140 | North Growth Management Ltd.VANCOUVER, A1 · 48 positions · $780M | +83.0% | +62.1 pts | +14% | +17% | +11% | +25% | CIENCiena Corp+22 pts of +83% · Held by Q2 2024 at $48.18, $491 at Q2 2026 |
| 141 | Velan Capital Investment Management LPALPHARETTA, GA · 50 positions · $163M | +82.3% | +61.4 pts | +31% | +31% | −1% | +7% | Cidara Therapeutics Inc+26 pts of +82% · First reported Q2 2025 at $48.71 |
| 142 | Checkpoint Capital L.P.SAN FRANCISCO, CA · 6 positions · $390M | +82.1% | +61.2 pts | +39% | +10% | −11% | +33% | ARGXArgenx SE - ADR+28 pts of +82% · Held by Q2 2024 at $430, $928 at Q2 2026 |
| 143 | Orion Resource Partners LPNEW YORK, NY · 24 positions · $219M | +81.0% | +60.1 pts | +39% | +29% | +11% | −9% | AAUCAllied Gold Corp+21 pts of +81% · First reported Q2 2025 at $13.43, $23.76 at Q2 2026 |
| 144 | Owl Creek Asset Management, L.P.New York, NY · 31 positions · $1.1B | +80.5% | +59.6 pts | +2% | −2% | +4% | +72% | ATEXAnterix Inc+79 pts of +81% · Held by Q2 2024 at $39.59, $103 at Q2 2026 |
| 145 | Summit Street Capital Management, LLCNEW YORK, NY · 31 positions · $713M | +80.4% | +59.6 pts | +22% | +3% | +18% | +21% | MUMicron Technology Inc+15 pts of +80% · Held by Q2 2024 at $132, $1,154 at Q2 2026 |
| 146 | Ws Management LllpJACKSONVILLE, FL · 31 positions · $850M | +80.4% | +59.5 pts | +10% | +9% | +4% | +44% | MUMicron Technology Inc+62 pts of +80% · Held by Q2 2024 at $132, $1,154 at Q2 2026 |
| 147 | Summit Partners Public Asset Management, LLCBoston, MA · 79 positions · $3.8B | +80.3% | +59.4 pts | +12% | +12% | +3% | +40% | SNDKSandisk Corp+15 pts of +80% · First reported Q2 2025 at $45.35, $2,274 at Q2 2026 |
| 148 | Atreides Management, LPBOSTON, MA · 46 positions · $11.1B | +79.8% | +58.9 pts | +21% | +7% | −7% | +49% | MUMicron Technology Inc+24 pts of +80% · Held by Q2 2024 at $132, $1,154 at Q2 2026 |
| 149 | Pivotal bioVenture Partners Investment Advisor LLCSAN FRANCISCO, CA · 13 positions · $308M | +79.0% | +58.1 pts | +19% | +38% | +11% | −2% | PCVXVaxcyte Inc+23 pts of +79% · Held by Q2 2024 at $75.51, $58.13 at Q2 2026 |
| 150 | Ardsley Advisory Partners LPNorwalk, CT · 130 positions · $921M | +78.6% | +57.7 pts | +18% | +11% | +3% | +33% | LITELumentum Holdings Inc+8 pts of +79% · First reported Q4 2024 at $83.95, $858 at Q2 2026 |
| 151 | Panview Capital LtdHONG KONG, K3 · 14 positions · $568M | +77.8% | +56.9 pts | +45% | +4% | −10% | +30% | INTCIntel Corp+23 pts of +78% · First reported Q1 2026 at $44.13, $140 at Q2 2026 |
| 152 | Encompass Capital Advisors LLCNew York, NY · 53 positions · $2.3B | +77.3% | +56.4 pts | +15% | +11% | +20% | +15% | TET1 Energy Inc+11 pts of +77% · Held by Q2 2024 at $1.70, $9.48 at Q2 2026 |
| 153 | Catalio Capital Management, LPNEW YORK, NY · 39 positions · $532M | +77.2% | +56.4 pts | +15% | +26% | −1% | +24% | DNTHDianthus Therapeutics Inc+13 pts of +77% · First reported Q4 2024 at $21.80, $97.48 at Q2 2026 |
| 154 | Alta Park Capital, LPSan Francisco, CA · 26 positions · $1.1B | +77.1% | +56.3 pts | +14% | +5% | +6% | +39% | WDCWestern Digital Corp+23 pts of +77% · First reported Q2 2025 at $63.99, $639 at Q2 2026 |
| 155 | Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance GroupWARSAW, R9 · 27 positions · $381M | +76.5% | +55.6 pts | +13% | +15% | −1% | +37% | MUMicron Technology Inc+28 pts of +76% · Held by Q2 2024 at $132, $1,154 at Q2 2026 |
| 156 | Alight Capital Management LPNew York, NY · 76 positions · $615M | +76.2% | +55.4 pts | +17% | +4% | −5% | +53% | INTCIntel Corp+11 pts of +76% · First reported Q3 2025 at $33.55, $140 at Q2 2026 |
| 157 | Clearfield Capital Management LPNEW YORK, NY · 5 positions · $143M | +76.2% | +55.3 pts | +18% | +3% | −1% | +46% | ECGEverus Construction Group+14 pts of +76% · First reported Q1 2025 at $37.09, $166 at Q2 2026 |
| 158 | Helix Partners Management LPNEW YORK, NY · 10 positions · $371M | +76.1% | +55.3 pts | +33% | −3% | +3% | +32% | CORZCore Scientific Inc+30 pts of +76% · First reported Q4 2024 at $14.05, $25.59 at Q2 2026 |
| 159 | Totem Point Management, LLCNew York, NY · 18 positions · $163M | +75.7% | +54.8 pts | +11% | +5% | −8% | +63% | AMDAdvanced Micro Devices+23 pts of +76% · Held by Q2 2024 at $162, $581 at Q2 2026 |
| 160 | Omega Fund Management, LLCBoston, MA · 10 positions · $186M | +75.3% | +54.4 pts | +45% | +42% | −35% | +30% | BCAXBicara Therapeutics Inc+36 pts of +75% · First reported Q3 2024 at $25.47, $29.69 at Q2 2026 |
| 161 | Tang Capital Management LLCSAN DIEGO, CA · 40 positions · $2.2B | +75.2% | +54.3 pts | +23% | +24% | +0% | +14% | SYRESpyre Therapeutics Inc+9 pts of +75% · First reported Q4 2025 at $32.76, $88.78 at Q2 2026 |
| 162 | Roubaix Capital, LLCDENVER, CO · 50 positions · $279M | +75.1% | +54.3 pts | +16% | +5% | −2% | +47% | VPGVishay Precision Group+10 pts of +75% · Held by Q2 2024 at $30.44, $150 at Q2 2026 |
| 163 | Front Street Capital Management, Inc.MISSOULA, MT · 70 positions · $881M | +75.0% | +54.2 pts | +15% | +11% | +11% | +24% | LITELumentum Holdings Inc+14 pts of +75% · Held by Q2 2024 at $50.92, $858 at Q2 2026 |
| 164 | Zweig-DiMenna Associates LLCNEW YORK, NY · 70 positions · $1.1B | +74.3% | +53.4 pts | +17% | +6% | −1% | +42% | LITELumentum Holdings Inc+8 pts of +74% · First reported Q4 2024 at $83.95, $858 at Q2 2026 |
| 165 | JW Asset Management, LLCMIAMI BEACH, FL · 21 positions · $320M | +73.3% | +52.4 pts | +2% | +46% | −19% | +44% | ESTAEstablishment Labs Holdings+66 pts of +73% · Held by Q2 2024 at $45.44, $85.81 at Q2 2026 |
| 166 | Palo Alto Investors LPPALO ALTO, CA · 52 positions · $724M | +73.2% | +52.3 pts | +26% | +25% | −1% | +12% | Amicus Therapeutics Inc+11 pts of +73% · Held by Q2 2024 at $9.92 |
| 167 | G2 Investment Partners Management LLCNew York, NY · 73 positions · $549M | +73.2% | +52.3 pts | +13% | −3% | −5% | +65% | TSEMTower Semiconductor Ltd+6 pts of +73% · First reported Q2 2025 at $43.35, $261 at Q2 2026 |
| 168 | Westerly Capital Management, LLCSAN FRANCISCO, CA · 46 positions · $542M | +73.1% | +52.2 pts | +22% | +3% | −2% | +40% | MRVLMarvell Technology Inc+17 pts of +73% · Held by Q2 2024 at $69.90, $298 at Q2 2026 |
| 169 | Rovida Investment Management LtdGrand Cayman, E9 · 20 positions · $1.5B | +72.6% | +51.7 pts | +40% | −14% | −0% | +44% | NBISNebius Group NV+64 pts of +73% · First reported Q2 2025 at $55.33, $276 at Q2 2026 |
| 170 | Vennlight Capital Management, LPWESTON, CT · 32 positions · $149M | +72.5% | +51.7 pts | +41% | −9% | +6% | +28% | HUTHut 8 Corp+16 pts of +73% · First reported Q4 2024 at $20.49, $115 at Q2 2026 |
| 171 | Softbank Group Corp.TOKYO, M0 · 30 positions · $18.2B | +72.4% | +51.5 pts | +10% | −6% | −1% | +69% | INTCIntel Corp+80 pts of +72% · First reported Q3 2025 at $33.55, $140 at Q2 2026 |
| 172 | Blue Owl Capital Holdings LPNew York, NY · 71 positions · $658M | +71.4% | +50.6 pts | +23% | +13% | +3% | +20% | AKTSAktis Oncology Inc+21 pts of +71% · First reported Q1 2026 at $17.89, $32.23 at Q2 2026 |
| 173 | Monaco Asset Management SAMMonaco, O9 · 36 positions · $269M | +71.2% | +50.3 pts | +27% | +17% | +11% | +4% | PTENPatterson-Uti Energy Inc+10 pts of +71% · First reported Q3 2024 at $7.65, $9.18 at Q2 2026 |
| 174 | Sessa Capital IM, L.P.NEW YORK, NY · 26 positions · $5.8B | +70.7% | +49.8 pts | +16% | +22% | −4% | +26% | WBDWarner Bros Discovery Inc+24 pts of +71% · Held by Q2 2024 at $7.44, $26.66 at Q2 2026 |
| 175 | Sagil Capital LLPLONDON, X0 · 19 positions · $205M | +70.2% | +49.4 pts | +17% | +14% | +32% | −4% | BBarrick Mining Corp+14 pts of +70% · First reported Q2 2025 at $20.82, $36.73 at Q2 2026 |
| 176 | General Pension Society PZU Joint Stock CoWARSAW, R9 · 16 positions · $668M | +70.2% | +49.3 pts | +13% | +15% | +4% | +25% | INTCIntel Corp+32 pts of +70% · Held by Q2 2024 at $30.97, $140 at Q2 2026 |
| 177 | Rivermont Capital Management LPNEW YORK, NY · 20 positions · $705M | +70.1% | +49.3 pts | +13% | +3% | +5% | +39% | STXSeagate Technology Holdings+24 pts of +70% · First reported Q3 2025 at $236, $965 at Q2 2026 |
| 178 | Anatole Investment Management LtdCENTRAL, K3 · 13 positions · $590M | +69.9% | +49.0 pts | +14% | +21% | +17% | +5% | SNDKSandisk Corp+34 pts of +70% · First reported Q3 2025 at $112, $2,274 at Q2 2026 |
| 179 | Baker Bros. Advisors LPNEW YORK, NY · 83 positions · $19.9B | +69.8% | +49.0 pts | +27% | +18% | −0% | +13% | INCYIncyte Corp+13 pts of +70% · Held by Q2 2024 at $60.62, $113 at Q2 2026 |
| 180 | Sarissa Capital Management LPGREENWICH, CT · 10 positions · $178M | +69.8% | +49.0 pts | +12% | +24% | +5% | +16% | IRWDIronwood Pharmaceuticals Inc+34 pts of +70% · Held by Q2 2024 at $6.52, $4.21 at Q2 2026 |
| 181 | Rtw Investments, LPNEW YORK, NY · 84 positions · $11.7B | +69.7% | +48.8 pts | +23% | +23% | −5% | +18% | Avidity Biosciences Inc Com+7 pts of +70% · Held by Q2 2024 at $40.85 |
| 182 | Maytus Capital Management, LLCNEW YORK, NY · 62 positions · $636M | +69.7% | +48.8 pts | +14% | +3% | −2% | +48% | WDCWestern Digital Corp+11 pts of +70% · Held by Q2 2024 at $75.77, $639 at Q2 2026 |
| 183 | Trybe Capital Management LPGREENWICH, CT · 7 positions · $929M | +68.5% | +47.6 pts | +14% | +7% | −6% | +45% | LRCXLam Research Corp+42 pts of +68% · First reported Q2 2025 at $97.34, $433 at Q2 2026 |
| 184 | Candelo Capital Management LPNEW YORK, NY · 27 positions · $136M | +68.4% | +47.6 pts | +11% | +1% | +17% | +29% | AMATApplied Materials Inc+8 pts of +68% · First reported Q4 2025 at $257, $723 at Q2 2026 |
| 185 | Jackson Square Capital, LLCSAN FRANCISCO, CA · 138 positions · $719M | +68.2% | +47.3 pts | +10% | +7% | +2% | +41% | MUMicron Technology Inc+26 pts of +68% · Held by Q2 2024 at $132, $1,154 at Q2 2026 |
| 186 | LM Asset Management Inc.VANCOUVER, A1 · 9 positions · $144M | +68.1% | +47.2 pts | +22% | +19% | +27% | −8% | LUMNLumen Technologies Inc+34 pts of +68% · First reported Q4 2024 at $5.31, $7.68 at Q2 2026 |
| 187 | Lansdowne Partners (Uk) LLPLondon, X0 · 26 positions · $2.4B | +67.9% | +47.1 pts | +12% | +5% | +6% | +35% | TSMTaiwan Semiconductor-Sp ADR+25 pts of +68% · Held by Q2 2024 at $174, $478 at Q2 2026 |
| 188 | Braidwell LPSTAMFORD, CT · 83 positions · $2.6B | +67.8% | +46.9 pts | +12% | +19% | +0% | +25% | EWTXEdgewise Therapeutics Inc+6 pts of +68% · First reported Q3 2024 at $26.69, $40.63 at Q2 2026 |
| 189 | Spectrum Financial Alliance Ltd LLCNICHOLASVILLE, KY · 31 positions · $679M | +67.8% | +46.9 pts | +10% | +10% | −0% | +38% | MUMicron Technology Inc+38 pts of +68% · Held by Q2 2024 at $132, $1,154 at Q2 2026 |
| 190 | Kerrisdale Advisers, LLCMiami, FL · 114 positions · $399M | +67.5% | +46.7 pts | +23% | +5% | +0% | +29% | STXSeagate Technology Holdings+15 pts of +68% · Held by Q2 2024 at $103, $965 at Q2 2026 |
| 191 | Mountaineer Partners Management, LLCNew York, NY · 11 positions · $137M | +67.3% | +46.5 pts | +11% | +17% | +15% | +12% | CENXCentury Aluminum Company+13 pts of +67% · Held by Q2 2024 at $16.75, $46.01 at Q2 2026 |
| 192 | Ophir Asset Management Pty LtdSYDNEY, C3 · 36 positions · $1.2B | +67.2% | +46.3 pts | +18% | −4% | +1% | +46% | SIMOSilicon Motion Technol-Adr+13 pts of +67% · First reported Q2 2025 at $75.17, $333 at Q2 2026 |
| 193 | Pennant Investors, LPSummit, NJ · 16 positions · $335M | +67.1% | +46.2 pts | +28% | +11% | +4% | +13% | ECHOEchostar Corp-A+31 pts of +67% · Held by Q2 2024 at $17.81, $102 at Q2 2026 |
| 194 | Juniper Investment Company, LLCNEW YORK, NY · 10 positions · $377M | +67.0% | +46.1 pts | +19% | +8% | +10% | +17% | LINCLincoln Educational Services+27 pts of +67% · Held by Q2 2024 at $11.86, $49.90 at Q2 2026 |
| 195 | Yu FanCENTRAL, HONG KONG, K3 · 8 positions · $108M | +66.8% | +45.9 pts | +11% | +34% | −4% | +17% | ALMSAlumis Inc+30 pts of +67% · Held by Q2 2024 at $13.30, $28.14 at Q2 2026 |
| 196 | Hill City Capital, LPBOSTON, MA · 28 positions · $4.3B | +66.6% | +45.7 pts | +18% | +9% | +2% | +27% | MTZMastec Inc+26 pts of +67% · Held by Q2 2024 at $107, $416 at Q2 2026 |
| 197 | Aegis Financial CorpMC LEAN, VA · 39 positions · $633M | +66.5% | +45.6 pts | +32% | +12% | +20% | −6% | EQXEquinox Gold Corp+17 pts of +66% · Held by Q2 2024 at $5.23, $9.72 at Q2 2026 |
| 198 | ACK Asset Management LLCGREENWICH, CT · 21 positions · $856M | +66.3% | +45.5 pts | +12% | +4% | +7% | +34% | MTRNMaterion Corp+16 pts of +66% · Held by Q2 2024 at $108, $297 at Q2 2026 |
| 199 | First Turn Management, LLCDEL MAR, CA · 31 positions · $935M | +66.3% | +45.5 pts | +17% | +19% | +2% | +17% | RVMDRevolution Medicines Inc+13 pts of +66% · Held by Q2 2024 at $38.81, $187 at Q2 2026 |
| 200 | Deerfield Management Company, L.P.New York, NY · 72 positions · $8.0B | +64.2% | +43.3 pts | +14% | +22% | +1% | +17% | Nuvalent Inc-A+16 pts of +64% · First reported Q4 2024 at $78.28, $124 at Q2 2026 |
Worst 12 months
The same funds, from the bottom| # | Fund | 12 months | vs S&P 500 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Biggest contributor |
|---|---|---|---|---|---|---|---|---|
| 1996 | Rubicon Global Capital LtdLondon, X0 · 12 positions · $273M | −59.2% | −80.0 pts | −26% | −16% | −38% | +6% | GOOGAlphabet Inc-Cl C+4 pts of −59% · First reported Q4 2024 at $190, $353 at Q2 2026 |
| 1995 | Woodbridge Co LtdToronto, A6 · 48 positions · $25.2B | −58.5% | −79.4 pts | −22% | −15% | −31% | −9% | GOOGLAlphabet Inc-Cl A+0 pts of −58% · First reported Q2 2025 at $176, $357 at Q2 2026 |
| 1994 | Clearlake Capital Group, L.P.SANTA MONICA, CA · 6 positions · $529M | −50.9% | −71.8 pts | −1% | −0% | −36% | −22% | HLLYHolley Inc+0 pts of −51% · Held by Q2 2024 at $3.58, $2.55 at Q2 2026 |
| 1993 | General Catalyst Group Management, LLCCAMBRIDGE, MA · 14 positions · $189M | −49.2% | −70.1 pts | −24% | −34% | −17% | +20% | AVBPArrivent Biopharma Inc+5 pts of −49% · Held by Q2 2024 at $18.55, $34.74 at Q2 2026 |
| 1992 | Aikya Investment Management LtdLONDON, X0 · 5 positions · $341M | −49.2% | −70.0 pts | −32% | +14% | −25% | −13% | INFYInfosys Ltd-Sp ADR−1 pts of −49% · Held by Q2 2024 at $18.62, $10.49 at Q2 2026 |
| 1991 | Technology Crossover Management IX, Ltd.MENLO PARK, CA · 6 positions · $690M | −44.4% | −65.3 pts | +2% | −11% | −33% | −8% | TRIPTripadvisor Inc+0 pts of −44% · Held by Q2 2024 at $17.81, $13.71 at Q2 2026 |
| 1990 | Caledonia (Private) Investments Pty LtdSydney Nsw, C3 · 17 positions · $2.9B | −43.0% | −63.9 pts | +2% | −8% | −33% | −9% | CCJCameco Corp+3 pts of −43% · First reported Q1 2025 at $41.16, $102 at Q2 2026 |
| 1989 | Battery Management Corp.BOSTON, MA · 5 positions · $368M | −37.0% | −57.8 pts | −6% | +7% | −37% | −2% | ZETAZeta Global Holdings Corp-A+0 pts of −37% · First reported Q4 2024 at $17.99, $19.68 at Q2 2026 |
| 1988 | ShawSpring Partners LLCBoston, MA · 11 positions · $232M | −36.5% | −57.3 pts | −8% | −9% | −26% | +4% | OKTAOkta Inc+5 pts of −36% · First reported Q2 2025 at $99.97, $136 at Q2 2026 |
| 1987 | ADW Capital Management, LLCMiami Beach, FL · 8 positions · $274M | −35.4% | −56.3 pts | −27% | −10% | −11% | +10% | CODICompass Diversified Holdings+3 pts of −35% · First reported Q1 2026 at $7.86, $10.66 at Q2 2026 |
| 1986 | Cerberus Capital Management, L.P.NEW YORK, NY · 11 positions · $2.1B | −35.3% | −56.2 pts | −17% | −2% | −1% | −20% | IONQIonq Inc+1 pts of −35% · First reported Q2 2025 at $42.97, $53.26 at Q2 2026 |
| 1985 | HMI Capital Management, L.P.SAN FRANCISCO, CA · 13 positions · $686M | −34.0% | −54.8 pts | −5% | −12% | −27% | +9% | Clearwater Analytics Hds-A+2 pts of −34% · First reported Q3 2025 at $18.02, $24.56 at Q2 2026 |
| 1984 | All-Stars Investment LtdHONG KONG, K3 · 11 positions · $199M | −32.9% | −53.7 pts | +10% | −18% | −23% | −3% | PDDPdd Holdings Inc+0 pts of −33% · Held by Q2 2024 at $133, $76.28 at Q2 2026 |
| 1983 | Whitebark Investors LPIncline Village, NV · 10 positions · $129M | −32.2% | −53.1 pts | +1% | −9% | −32% | +10% | TDSTelephone and Data Systems+2 pts of −32% · First reported Q1 2025 at $38.74, $37.01 at Q2 2026 |
| 1982 | Greenhaven Road Investment Management, L.P.GREENWICH, CT · 17 positions · $154M | −31.5% | −52.4 pts | −10% | −0% | −31% | +12% | ASTSAst Spacemobile Inc+5 pts of −32% · First reported Q2 2025 at $46.73, $88.86 at Q2 2026 |
| 1981 | WFM ASIA (BVI) LtdHONG KONG, K3 · 5 positions · $663M | −31.5% | −52.3 pts | +15% | −16% | −27% | −2% | HTHTH World Group Ltd-Adr+3 pts of −31% · Held by Q2 2024 at $33.32, $41.72 at Q2 2026 |
| 1980 | StepStone Group LPLa Jolla, CA · 23 positions · $2.2B | −31.4% | −52.3 pts | −0% | −7% | −38% | +19% | XNDUXanadu Quantum Technolo-Cl B+4 pts of −31% · First reported Q1 2026 at $7.66, $12.11 at Q2 2026 |
| 1979 | Orland Properties LtdWashington, DC · 10 positions · $202M | −31.4% | −52.2 pts | −21% | +14% | −19% | −5% | XPEVXpeng Inc - ADR+2 pts of −31% · Held by Q2 2024 at $7.33, $13.24 at Q2 2026 |
| 1978 | ICONIQ Capital, LLCSAN FRANCISCO, CA · 76 positions · $3.5B | −31.1% | −52.0 pts | −1% | −7% | −31% | +8% | AMDAdvanced Micro Devices+2 pts of −31% · Held by Q2 2024 at $162, $581 at Q2 2026 |
| 1977 | OLP CAPITAL MANAGEMENT LtdCAUSEWAY BAY, K3 · 6 positions · $400M | −30.1% | −50.9 pts | −4% | −7% | −12% | −11% | JOYYJoyy Inc-Adr+1 pts of −30% · First reported Q4 2024 at $41.85, $65.99 at Q2 2026 |
| 1976 | Long Path Partners LPStamford, CT · 10 positions · $235M | −29.4% | −50.3 pts | −4% | −7% | −25% | +6% | MLABMesa Laboratories Inc+2 pts of −29% · First reported Q4 2025 at $78.50, $99.55 at Q2 2026 |
| 1975 | Fernbridge Capital Management LPLOS ANGELES, CA · 16 positions · $1.4B | −28.8% | −49.7 pts | +1% | −3% | −21% | −9% | TSMTaiwan Semiconductor-Sp ADR+1 pts of −29% · First reported Q4 2024 at $197, $478 at Q2 2026 |
| 1974 | Partners Group Holding AGBAAR-ZUG, V8 · 52 positions · $1.5B | −28.5% | −49.3 pts | −14% | −13% | −16% | +14% | CSXCsx Corp+1 pts of −28% · Held by Q2 2024 at $33.45, $47.53 at Q2 2026 |
| 1973 | Valor Management LLCCHICAGO, IL · 5 positions · $86.2B | −28.5% | −49.3 pts | −10% | +31% | −30% | −14% | HRMYHarmony Biosciences Holdings+4 pts of −28% · Held by Q2 2024 at $30.17, $36.41 at Q2 2026 |
| 1972 | Atairos Group, Inc.Bryn Mawr, PA · 5 positions · $1.8B | −28.2% | −49.1 pts | −2% | −13% | −26% | +15% | XPOFXponential Fitness Inc-A−0 pts of −28% · First reported Q2 2025 at $7.49, $6.92 at Q2 2026 |
A fund's return here is what its reported stock positions earned if it held each quarter-end portfolio unchanged until the next quarter end, at the median price all 13F filers reported, without dividends, fees or trading in between. It ranks the portfolios funds disclosed, not the returns their investors got. "Skill" is the luck-adjusted return over stocks of the same sector and size, per year; "Quarters ahead" counts the quarters the fund beat that benchmark. The biggest contributor is the stock that added the most points to that return, with the quarter the fund first reported it and the 13F price then. Broad winners leaves out funds with fewer than 10 positions or one stock behind more than half the return, since a single bet that paid off says little about a manager. Funds need four quarters of holdings priced at least 70% by value. When we tested it over 2024 to 2025, a fund's rank one year did not predict its rank the next (rank correlation −0.016), so a high rank is a record, not a forecast. How this works.